© 2000-2019 QIAGEN. All rights reserved.

Analysis Details for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Workspace	My Projects
Project	AIH_WGCNA
Analysis	top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Date	Thu May 09 22:09:57 PDT 2019
Analysis ID	17791075

Analysis Settings
Cutoff before duplicate resolution	true
Reference set	Ingenuity Knowledge Base (Genes Only)
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	No
Optional Analyses	My Pathways My List
Filter Summary	
Consider only relationships where
confidence = Experimentally Observed

Canonical Pathways for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
Axonal Guidance Signaling	5.13E-01	NaN	2.00E-03	KEL,	
Xenobiotic Metabolism Signaling	7.03E-01	NaN	3.30E-03	FTL,	
Sirtuin Signaling Pathway	7.17E-01	NaN	3.42E-03	SLC2A1,	
AMPK Signaling	8.19E-01	NaN	4.42E-03	SLC2A1,	
NRF2-mediated Oxidative Stress Response	8.56E-01	NaN	4.85E-03	FTL,	
Acute Phase Response Signaling	9.13E-01	NaN	5.59E-03	FTL,	
Iron homeostasis signaling pathway	1.02E00	NaN	7.30E-03	FTL,	
HIF1α Signaling	1.05E00	NaN	7.75E-03	SLC2A1,	
Antioxidant Action of Vitamin C	1.11E00	NaN	9.01E-03	SLC2A1,	
TR/RXR Activation	1.15E00	NaN	1.00E-02	SLC2A1,	
IL-7 Signaling Pathway	1.19E00	NaN	1.08E-02	SLC2A1,	
Renal Cell Carcinoma Signaling	1.19E00	NaN	1.08E-02	SLC2A1,	
Autophagy	1.36E00	NaN	1.64E-02	CTSB,	
SPINK1 Pancreatic Cancer Pathway	1.37E00	NaN	1.67E-02	CTSB,	
PFKFB4 Signaling Pathway	1.48E00	NaN	2.17E-02	HK1,	
BAG2 Signaling Pathway	1.51E00	NaN	2.33E-02	CTSB,	
Inflammasome pathway	1.84E00	NaN	5.00E-02	CTSB,	
Vitamin-C Transport	1.94E00	NaN	6.25E-02	SLC2A1,	
Glucose and Glucose-1-phosphate Degradation	2.1E00	NaN	9.09E-02	HK1,	
UDP-N-acetyl-D-galactosamine Biosynthesis II	2.1E00	NaN	9.09E-02	HK1,	
GDP-glucose Biosynthesis	2.14E00	NaN	1.00E-01	HK1,	
Phagosome Maturation	2.3E00	NaN	1.35E-02	RILP,CTSB	
Trehalose Degradation II (Trehalase)	2.44E00	NaN	2.00E-01	HK1,	

Upstream Regulators for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Analysis	ID	Upstream Regulator	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MLIP	other	 	 	 	 	 	5.07E-07	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	KLF1	transcription regulator	 	 	 	 	 	4.86E-06	BSG,KEL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ATG7	enzyme	 	 	 	 	 	1.59E-05	CTSB,HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PIK3CB	kinase	 	 	 	 	 	3.33E-05	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	RBBP7	transcription regulator	 	 	 	 	 	3.94E-05	KLF1,LYL1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CD46	other	 	 	 	 	 	7.71E-05	SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	L-dopa	chemical - endogenous mammalian	 	 	 	 	 	9.32E-05	CTSB,FTL,RILP,SLC2A1,TMCC2	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IDO1	enzyme	 	 	 	 	 	1.06E-04	SLC1A5,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SYVN1	transporter	 	 	 	 	 	1.26E-04	SLC1A5,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TCR	complex	 	 	 	 	 	1.33E-04	BSG,CTSB,SLC1A5,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MTA2	transcription regulator	 	 	 	 	 	1.63E-04	KLF1,LYL1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PRKCI	kinase	 	 	 	 	 	2.18E-04	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PRKAG3	other	 	 	 	 	 	2.27E-04	FTL,SLC2A1,TMCC2	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PRMT1	enzyme	 	 	 	 	 	3.15E-04	FTL,KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CSF2	cytokine	 	 	 	 	 	3.59E-04	BSG,KLF1,SLC1A5,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABCB6	transporter	 	 	 	 	 	4.50E-04	HK1,KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CSF1	cytokine	 	 	 	 	 	5.05E-04	SLC1A5,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	BAG2	other	 	 	 	 	 	7.36E-04	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CDC42BPB	kinase	 	 	 	 	 	7.36E-04	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GSE1	other	 	 	 	 	 	7.36E-04	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Ggt	group	 	 	 	 	 	7.36E-04	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NBR2	other	 	 	 	 	 	7.36E-04	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC2A12	transporter	 	 	 	 	 	7.36E-04	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	azide	chemical reagent	 	 	 	 	 	7.36E-04	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IL5	cytokine	 	 	 	 	 	1.13E-03	SLC1A5,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TGFB1	growth factor	 	 	 	 	 	1.25E-03	BSG,CTSB,FTL,HK1,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GCG	other	 	 	 	 	 	1.36E-03	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	8-aminoadenosine	chemical reagent	 	 	 	 	 	1.47E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Alpha 1 antitrypsin	group	 	 	 	 	 	1.47E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TXNDC5	enzyme	 	 	 	 	 	1.47E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	dimethyl succinate	chemical - endogenous mammalian	 	 	 	 	 	1.47E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	gliclazide	chemical drug	 	 	 	 	 	1.47E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	glucose oxidase	group	 	 	 	 	 	1.47E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	hemin	chemical - endogenous mammalian	 	 	 	 	 	1.59E-03	FTL,KEL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TFRC	transporter	 	 	 	 	 	1.67E-03	FTL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IL3	cytokine	 	 	 	 	 	1.85E-03	HK1,KLF1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CTNS	transporter	 	 	 	 	 	2.21E-03	RILP	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FTMT	enzyme	 	 	 	 	 	2.21E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GLUD1	enzyme	 	 	 	 	 	2.21E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PPP1R3C	phosphatase	 	 	 	 	 	2.21E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC48A1	transporter	 	 	 	 	 	2.21E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	chemical reagent	 	 	 	 	 	2.21E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	interferon beta-1b	biologic drug	 	 	 	 	 	2.21E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	glutamine	chemical - endogenous mammalian	 	 	 	 	 	2.36E-03	BSG,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IFNG	cytokine	 	 	 	 	 	2.39E-03	CTSB,FTL,KLF1,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	dexamethasone	chemical drug	 	 	 	 	 	2.48E-03	BSG,CTSB,FTL,OSBP2,SLC2A1,SPECC1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	caffeic acid phenethyl ester	chemical drug	 	 	 	 	 	2.60E-03	CTSB,FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GATA2	transcription regulator	 	 	 	 	 	2.87E-03	KEL,KLF1,LYL1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABCC9	ion channel	 	 	 	 	 	2.94E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HCAR1	g-protein coupled receptor	 	 	 	 	 	2.94E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PAK4	kinase	 	 	 	 	 	2.94E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	RPRD1A	other	 	 	 	 	 	2.94E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	firtecan pegol	chemical drug	 	 	 	 	 	2.94E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	methylamine	chemical - endogenous mammalian	 	 	 	 	 	2.94E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	phenformin	chemical drug	 	 	 	 	 	2.94E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PI3K (family)	group	 	 	 	 	 	3.01E-03	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SRC	kinase	 	 	 	 	 	3.11E-03	CTSB,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CDR2	other	 	 	 	 	 	3.67E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PINK1	kinase	 	 	 	 	 	3.67E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	temsirolimus	chemical drug	 	 	 	 	 	3.67E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	VHL	transcription regulator	 	 	 	 	 	4.27E-03	FTL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABCB7	transporter	 	 	 	 	 	4.41E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	APBA3	transporter	 	 	 	 	 	4.41E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Cbp/p300-Maf-Nfe2l2	complex	 	 	 	 	 	4.41E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Plin2	other	 	 	 	 	 	4.41E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC16A1	transporter	 	 	 	 	 	4.41E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SSPN	other	 	 	 	 	 	4.41E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	WDFY2	other	 	 	 	 	 	4.41E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ferric chloride	chemical toxicant	 	 	 	 	 	4.41E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	histidinol	chemical - endogenous mammalian	 	 	 	 	 	4.41E-03	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	2-mercaptoethanol	chemical - endogenous mammalian	 	 	 	 	 	5.14E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABL2	kinase	 	 	 	 	 	5.14E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CTSE	peptidase	 	 	 	 	 	5.14E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	LRP2	transporter	 	 	 	 	 	5.14E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SDHA	enzyme	 	 	 	 	 	5.14E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SNED1	other	 	 	 	 	 	5.14E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TDO2	enzyme	 	 	 	 	 	5.14E-03	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	pictilisib	chemical drug	 	 	 	 	 	5.14E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	AQP4	transporter	 	 	 	 	 	5.87E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NELFCD	other	 	 	 	 	 	5.87E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	collagen	group	 	 	 	 	 	5.87E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	glimepiride	chemical drug	 	 	 	 	 	5.87E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ATF4	transcription regulator	 	 	 	 	 	5.96E-03	SLC1A5,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CD38	enzyme	 	 	 	 	 	6.10E-03	SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HBP1	transcription regulator	 	 	 	 	 	6.60E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MPL	transmembrane receptor	 	 	 	 	 	6.60E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NELFA	other	 	 	 	 	 	6.60E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NELFE	other	 	 	 	 	 	6.60E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC2A1	transporter	 	 	 	 	 	6.60E-03	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ST6GAL1	enzyme	 	 	 	 	 	6.60E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	cysteamine	chemical drug	 	 	 	 	 	6.60E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FFAR1	g-protein coupled receptor	 	 	 	 	 	7.33E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FTH1	enzyme	 	 	 	 	 	7.33E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Irp	group	 	 	 	 	 	7.33E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	KDM8	enzyme	 	 	 	 	 	7.33E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	VLDLR	transporter	 	 	 	 	 	7.33E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	astressin 2B	biologic drug	 	 	 	 	 	7.33E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	dihydrotestosterone	chemical - endogenous mammalian	 	 	 	 	 	7.40E-03	FTL,SLC1A5,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	topotecan	chemical drug	 	 	 	 	 	7.82E-03	SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	AIMP2	other	 	 	 	 	 	8.06E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CA074-methyl ester	chemical reagent	 	 	 	 	 	8.06E-03	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CCNT1	transcription regulator	 	 	 	 	 	8.06E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NLRX1	other	 	 	 	 	 	8.06E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TAS1R3	g-protein coupled receptor	 	 	 	 	 	8.06E-03	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ferric ammonium citrate	chemical drug	 	 	 	 	 	8.06E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	teriflunomide	chemical drug	 	 	 	 	 	8.06E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MYC	transcription regulator	 	 	 	 	 	8.13E-03	CTSB,SLC1A5,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PDX1	transcription regulator	 	 	 	 	 	8.24E-03	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ACO1	enzyme	 	 	 	 	 	8.79E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IREB2	translation regulator	 	 	 	 	 	8.79E-03	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SORT1	g-protein coupled receptor	 	 	 	 	 	8.79E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	etoposide	chemical drug	 	 	 	 	 	8.84E-03	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HIF3A	transcription regulator	 	 	 	 	 	9.52E-03	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PPIA	enzyme	 	 	 	 	 	9.52E-03	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	progesterone	chemical - endogenous mammalian	 	 	 	 	 	9.66E-03	BSG,SLC1A5,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FN1	enzyme	 	 	 	 	 	9.91E-03	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	BET	group	 	 	 	 	 	1.03E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HIRA	transcription regulator	 	 	 	 	 	1.03E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NFkB (family)	group	 	 	 	 	 	1.03E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NPFF	other	 	 	 	 	 	1.03E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SMPD1	enzyme	 	 	 	 	 	1.03E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	xanthine	chemical - endogenous mammalian	 	 	 	 	 	1.03E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	EPAS1	transcription regulator	 	 	 	 	 	1.07E-02	SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	beta-estradiol	chemical - endogenous mammalian	 	 	 	 	 	1.08E-02	BSG,CTSB,LYL1,SLC2A1,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ADP	chemical - endogenous mammalian	 	 	 	 	 	1.10E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CLCN5	ion channel	 	 	 	 	 	1.10E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ENPP2	enzyme	 	 	 	 	 	1.10E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PNN	other	 	 	 	 	 	1.10E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	pomalidomide	chemical drug	 	 	 	 	 	1.10E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	selumetinib	chemical drug	 	 	 	 	 	1.10E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	D-glucose	chemical - endogenous mammalian	 	 	 	 	 	1.11E-02	CTSB,HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	cholesterol	chemical - endogenous mammalian	 	 	 	 	 	1.14E-02	BSG,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HIF1AN	enzyme	 	 	 	 	 	1.17E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	mir-194	microrna	 	 	 	 	 	1.17E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SMAD6	transcription regulator	 	 	 	 	 	1.24E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	batimastat	chemical - protease inhibitor	 	 	 	 	 	1.24E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	glyburide	chemical drug	 	 	 	 	 	1.24E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ADCYAP1	other	 	 	 	 	 	1.27E-02	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	actinomycin D	biologic drug	 	 	 	 	 	1.31E-02	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CRHR1	g-protein coupled receptor	 	 	 	 	 	1.32E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	indomethacin	chemical drug	 	 	 	 	 	1.36E-02	BSG,SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	DAG1	transmembrane receptor	 	 	 	 	 	1.39E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FLNA	other	 	 	 	 	 	1.39E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SCP2	transporter	 	 	 	 	 	1.39E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	isoprenaline	chemical drug	 	 	 	 	 	1.39E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	mir-143	microrna	 	 	 	 	 	1.39E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	BID	other	 	 	 	 	 	1.46E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PPP1R13L	transcription regulator	 	 	 	 	 	1.46E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TFAM	transcription regulator	 	 	 	 	 	1.46E-02	HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ammonium chloride	chemical drug	 	 	 	 	 	1.46E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	cigarette smoke	chemical toxicant	 	 	 	 	 	1.47E-02	FTL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NTN1	other	 	 	 	 	 	1.53E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC2A4	transporter	 	 	 	 	 	1.53E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	dichloroacetic acid	chemical drug	 	 	 	 	 	1.53E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TNFSF11	cytokine	 	 	 	 	 	1.57E-02	BSG,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CRHR2	g-protein coupled receptor	 	 	 	 	 	1.61E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	L-tryptophan	chemical - endogenous mammalian	 	 	 	 	 	1.61E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ketamine	chemical drug	 	 	 	 	 	1.61E-02	HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ALDH2	enzyme	 	 	 	 	 	1.68E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NFE2	transcription regulator	 	 	 	 	 	1.68E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SEMA7A	transmembrane receptor	 	 	 	 	 	1.68E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MAPT	other	 	 	 	 	 	1.70E-02	BSG,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	cisplatin	chemical drug	 	 	 	 	 	1.79E-02	CTSB,HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Calcineurin A	group	 	 	 	 	 	1.82E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HEXIM1	transcription regulator	 	 	 	 	 	1.82E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	BMPR1B	kinase	 	 	 	 	 	1.90E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	EIF4EBP1	translation regulator	 	 	 	 	 	1.90E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NOS1	enzyme	 	 	 	 	 	1.90E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SKP2	enzyme	 	 	 	 	 	1.90E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	arsenic	chemical toxicant	 	 	 	 	 	1.90E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GATA1	transcription regulator	 	 	 	 	 	1.93E-02	KLF1,LYL1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	RXRA	ligand-dependent nuclear receptor	 	 	 	 	 	1.97E-02	CTSB,FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	hydroxypropyl-beta-cyclodextrin	chemical drug	 	 	 	 	 	1.97E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	VEGFA	growth factor	 	 	 	 	 	1.98E-02	CTSB,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CD47	transmembrane receptor	 	 	 	 	 	2.04E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CA4	enzyme	 	 	 	 	 	2.11E-02	KEL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NPC2	transporter	 	 	 	 	 	2.11E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SMAD5	transcription regulator	 	 	 	 	 	2.11E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	UBE2I	enzyme	 	 	 	 	 	2.11E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	indican	chemical - endogenous mammalian	 	 	 	 	 	2.19E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IFRD1	other	 	 	 	 	 	2.26E-02	HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TG	other	 	 	 	 	 	2.26E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TRPM2	ion channel	 	 	 	 	 	2.26E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NOX4	enzyme	 	 	 	 	 	2.33E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Stat3-Stat3	complex	 	 	 	 	 	2.33E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	everolimus	chemical drug	 	 	 	 	 	2.33E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SLC16A2	transporter	 	 	 	 	 	2.40E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	lactic acid	chemical - endogenous mammalian	 	 	 	 	 	2.40E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	mir-150	microrna	 	 	 	 	 	2.40E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABCG1	transporter	 	 	 	 	 	2.47E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Secretase gamma	complex	 	 	 	 	 	2.47E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	arginine	chemical - endogenous mammalian	 	 	 	 	 	2.47E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IL1	group	 	 	 	 	 	2.59E-02	CTSB,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MTOR	kinase	 	 	 	 	 	2.64E-02	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	APP	other	 	 	 	 	 	2.64E-02	BSG,CTSB,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ELANE	peptidase	 	 	 	 	 	2.69E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	XDH	enzyme	 	 	 	 	 	2.69E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	APR-246	chemical drug	 	 	 	 	 	2.76E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NR1D1	ligand-dependent nuclear receptor	 	 	 	 	 	2.76E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SPRY2	other	 	 	 	 	 	2.76E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	nitrofen	chemical toxicant	 	 	 	 	 	2.76E-02	HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CARM1	transcription regulator	 	 	 	 	 	2.83E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Cdc42	enzyme	 	 	 	 	 	2.83E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NEDD9	other	 	 	 	 	 	2.83E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TFEB	transcription regulator	 	 	 	 	 	2.83E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	bromocriptine	chemical drug	 	 	 	 	 	2.83E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABL1	kinase	 	 	 	 	 	2.90E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FLT3	kinase	 	 	 	 	 	2.90E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PLAUR	transmembrane receptor	 	 	 	 	 	2.90E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IRS2	enzyme	 	 	 	 	 	2.97E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	KCNK9	ion channel	 	 	 	 	 	2.97E-02	KEL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	T3-TR-RXR	complex	 	 	 	 	 	2.97E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	nonylphenol	chemical toxicant	 	 	 	 	 	2.97E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IFNE	cytokine	 	 	 	 	 	3.05E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PCGEM1	other	 	 	 	 	 	3.05E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PKM	kinase	 	 	 	 	 	3.05E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	troglitazone	chemical drug	 	 	 	 	 	3.08E-02	OSBP2,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	4-hydroxynonenal	chemical toxicant	 	 	 	 	 	3.12E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	D-galactosamine	chemical - endogenous mammalian	 	 	 	 	 	3.12E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ibuprofen	chemical drug	 	 	 	 	 	3.12E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	APLN	other	 	 	 	 	 	3.19E-02	LYL1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SKIL	transcription regulator	 	 	 	 	 	3.19E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	advanced glycation end-products	chemical - endogenous mammalian	 	 	 	 	 	3.19E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	A2M	transporter	 	 	 	 	 	3.26E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IDH1	enzyme	 	 	 	 	 	3.26E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	LPL	enzyme	 	 	 	 	 	3.26E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PSEN1	peptidase	 	 	 	 	 	3.31E-02	BSG,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ABCA1	transporter	 	 	 	 	 	3.33E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Hbb-b2	other	 	 	 	 	 	3.33E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MYBL2	transcription regulator	 	 	 	 	 	3.33E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SPHK1	kinase	 	 	 	 	 	3.33E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IL13	cytokine	 	 	 	 	 	3.37E-02	CTSB,HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Insulin	group	 	 	 	 	 	3.37E-02	FTL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	INSR	kinase	 	 	 	 	 	3.40E-02	CTSB,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FGF21	growth factor	 	 	 	 	 	3.40E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SIRT3	enzyme	 	 	 	 	 	3.40E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	genistein	chemical drug	 	 	 	 	 	3.43E-02	CTSB,SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TAF7L	transcription regulator	 	 	 	 	 	3.55E-02	HK1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	APOA1	transporter	 	 	 	 	 	3.69E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MSTN	growth factor	 	 	 	 	 	3.76E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	MTORC1	complex	 	 	 	 	 	3.76E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	inosine	chemical - endogenous mammalian	 	 	 	 	 	3.76E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	BAX	transporter	 	 	 	 	 	3.83E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CD3 group	group	 	 	 	 	 	3.83E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	miR-133a-3p (and other miRNAs w/seed UUGGUCC)	mature microrna	 	 	 	 	 	3.83E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	salirasib	chemical drug	 	 	 	 	 	3.83E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NFE2L2	transcription regulator	 	 	 	 	 	3.86E-02	FTL,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NKX3-1	transcription regulator	 	 	 	 	 	3.90E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SHC1	other	 	 	 	 	 	3.90E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	iron	chemical - endogenous mammalian	 	 	 	 	 	3.90E-02	FTL	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Ccl2	cytokine	 	 	 	 	 	3.97E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	FGF10	growth factor	 	 	 	 	 	3.97E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ELK1	transcription regulator	 	 	 	 	 	4.04E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	H2AFY	other	 	 	 	 	 	4.04E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	di(2-ethylhexyl) phthalate	chemical toxicant	 	 	 	 	 	4.04E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	pirinixic acid	chemical toxicant	 	 	 	 	 	4.10E-02	BSG,CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	NCOR2	transcription regulator	 	 	 	 	 	4.11E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SCD	enzyme	 	 	 	 	 	4.18E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	rotenone	chemical toxicant	 	 	 	 	 	4.18E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	butyric acid	chemical - endogenous mammalian	 	 	 	 	 	4.20E-02	HK1,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CSHL1	growth factor	 	 	 	 	 	4.25E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CHD4	enzyme	 	 	 	 	 	4.33E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TYROBP	transmembrane receptor	 	 	 	 	 	4.33E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SNAI2	transcription regulator	 	 	 	 	 	4.40E-02	BSG	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	EGLN1	enzyme	 	 	 	 	 	4.47E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	Hif1	complex	 	 	 	 	 	4.47E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PDCD1	phosphatase	 	 	 	 	 	4.47E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	TSH	complex	 	 	 	 	 	4.68E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	IGF1	growth factor	 	 	 	 	 	4.72E-02	BSG,SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CRH	cytokine	 	 	 	 	 	4.75E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	SGK1	kinase	 	 	 	 	 	4.75E-02	SLC1A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	caffeine	chemical drug	 	 	 	 	 	4.75E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	infliximab	biologic drug	 	 	 	 	 	4.75E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	HIPK2	kinase	 	 	 	 	 	4.82E-02	KLF1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	PLAU	peptidase	 	 	 	 	 	4.89E-02	SLC2A1	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	ANXA7	ion channel	 	 	 	 	 	4.96E-02	CTSB	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	CTLA4	transmembrane receptor	 	 	 	 	 	4.96E-02	SLC7A5	 	
top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	 	GDNF	growth factor	 	 	 	 	 	4.96E-02	CTSB	 	

Causal Networks for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Master Regulator	Molecule Type	Depth	Predicted Activation State	Notes	Activation z-score	p-value of overlap	Network bias-corrected p-value	Participating regulators	Target molecules in dataset	Causal network	Target-connected regulators	Relationships Between Master Regulators(Increases/Downstream)	Relationships Between Master Regulators(Decreases/Downstream)	Relationships Between Master Regulators(Affects/Downstream)	Relationships Between Master Regulators(Increases/Upstream)	Relationships Between Master Regulators(Decreases/Upstream)	Relationships Between Master Regulators(Affects/Upstream)	Relationships Between Master Regulators(Increases/Both)	Relationships Between Master Regulators(Decreases/Both)	Relationships Between Master Regulators(Affects/Both)	
MLIP	other	1	 	 	0.000	5.07E-07	1.00E-04	MLIP	 	2 (1)	1	 	 	 	SLC2A1	EIF4EBP1	 	 	 	 	
sialic acids	chemical - other	3	 	 	0.000	6.78E-06	2.90E-03	CDH5,EGFR,ERK1/2,LYN,NFkB (complex),PI3K (complex),Sfk,SHC1,sialic acids,SRC,STAT3,TCR	 	8 (12)	9	 	 	 	 	 	 	 	 	 	
ATG7	enzyme	1	 	 	0.000	1.15E-05	2.00E-04	ATG7	 	3 (1)	1	TRPM2	PI3K (family)	 	SLC2A1	ATF4	 	 	 	 	
resimmune	biologic drug	3	 	 	0.000	1.16E-05	3.70E-03	AMPK,CD247,ERK1/2,HRAS,ITK,LAT,MAPK1,NFkB (complex),PI3K (complex),resimmune,SHC1,TCR,ZAP70	 	8 (13)	9	 	 	 	ZAP70	 	 	 	 	 	
SIGLEC7	transmembrane receptor	3	 	 	0.000	1.23E-05	4.60E-03	CSF2,ERK1/2,Nfat (family),NFkB (complex),PI3K (complex),SHC1,SIGLEC7,TCR,ZAP70	 	8 (9)	6	TCR	 	 	 	ZAP70	 	 	 	 	
SMAD2	transcription regulator	2	 	 	0.000	1.95E-05	5.50E-03	ERK1/2,MTOR,SKIL,SMAD2,SP1,STAT3,TGFB1	 	8 (7)	6	IL5,SDC2	NEDD4L,NOS1,SMAD6	 	 	 	 	 	 	 	
PIK3CB	kinase	1	 	 	0.000	2.28E-05	2.00E-04	PIK3CB	 	2 (1)	1	SRC,TCR	pictilisib	 	PI3K (family),SLC2A1	 	 	 	 	 	
ZAP70	kinase	2	 	 	0.000	2.56E-05	8.70E-03	ERK1/2,NFkB (complex),PI3K (complex),SHC1,TCR,ZAP70	 	7 (6)	5	resimmune,SRC	SIGLEC7	 	NFE2	 	 	 	 	 	
TCR	complex	1	 	 	0.000	3.05E-05	6.00E-04	TCR	 	4 (1)	1	 	FN1	 	CSF2,GATA3,IL5,PIK3CB,PRMT1,SIGLEC7,SLC2A1,STAT4,TGFB1	BAD,SDHA	 	 	 	 	
abatacept	biologic drug	3	 	 	0.000	3.55E-05	9.00E-03	abatacept,CD80,CD86,IDO1,IFNG,IL4,PI3K (complex)	 	8 (7)	4	 	 	 	IDO1	 	 	 	 	 	
CD46	other	1	 	 	0.000	6.86E-05	8.00E-04	CD46	 	2 (1)	1	SRC,SYVN1	TGFB1	 	SLC2A1	 	 	 	 	 	
L-dopa	chemical - endogenous mammalian	1	 	 	0.000	9.19E-05	5.00E-04	L-dopa	 	5 (1)	1	 	 	 	C1QTNF12,IDO1,NEDD4L,SLC2A1	PRKD3,SKP2	 	 	 	 	
NEDD4L	enzyme	2	 	 	0.000	9.21E-05	1.62E-02	NEDD4L,PIK3R1,SGK1,SKIL,TGFB1	 	7 (5)	4	L-dopa	 	 	 	SMAD2,TGFB1	 	 	 	 	
IDO1	enzyme	1	 	 	0.000	9.57E-05	4.00E-04	IDO1	 	2 (1)	1	abatacept,CSF2,hemin,L-dopa	2-mercaptoethanol	 	 	FCGR1A,GATA3,mir-143	 	 	 	 	
PRMT1	enzyme	1	 	 	0.000	9.57E-05	7.00E-04	PRMT1	 	2 (1)	1	TCR	 	 	FTH1,KLF1,NFE2	 	 	 	 	 	
FURIN	peptidase	2	 	 	0.000	1.08E-04	1.86E-02	AKT1,BMP4,ERK1/2,FURIN,MMP9,TGFB1	 	7 (6)	5	STAT4	 	 	ADAM12	 	 	 	 	 	
SDC2	other	2	 	 	0.000	1.10E-04	1.28E-02	CSF2,MAPK1,PI3K (complex),SDC2	 	6 (4)	3	 	 	 	SMAD2	 	 	 	 	 	
BAD	other	2	 	 	0.000	1.11E-04	5.90E-03	BAD,BAX,CSF2	 	5 (3)	2	dichloroacetic acid,STAT4	IL3,PAK4,PI3K (family),PRKCI,TCR,TGFB1	 	 	 	 	 	 	 	
SYVN1	transporter	1	 	 	0.000	1.26E-04	8.00E-04	SYVN1	 	3 (1)	1	 	 	 	CD46,DAG1,SLC2A1	HMGCR	 	 	 	 	
CLC	enzyme	3	 	 	0.000	1.35E-04	9.80E-03	CEBPA,CLC,HRAS,IL6ST,JAK1,JAK2,MITF,NOS2,PI3K (complex),SHC1,SP1,STAT1,STAT3,STAT4,TYK2	 	9 (15)	9	 	 	 	 	 	 	 	 	 	
CRLF1	other	3	 	 	0.000	1.38E-04	1.03E-02	CEBPA,CRLF1,HRAS,IL6ST,JAK1,JAK2,MITF,NOS2,PI3K (complex),SHC1,SP1,STAT,STAT1,STAT3,STAT4,TYK2	 	9 (16)	9	 	 	 	 	 	 	 	 	 	
IL5	cytokine	2	 	 	0.000	1.54E-04	2.62E-02	ERK1/2,HRAS,IL5,LYN,MAPK1,PI3K (complex)	 	7 (6)	6	GATA3,TCR	dichloroacetic acid,ganglioside GD1b,hemin,PPIA	 	ATF4,CA4,CSF2RB,EIF4EBP1,Ggt,HMGCR,NFE2,SLC2A1,SMAD2	 	 	 	 	 	
8-epi-prostaglandin F2alpha	chemical - endogenous mammalian	3	 	 	0.000	1.56E-04	3.70E-03	8-epi-prostaglandin F2alpha,EDN1,HRAS,MITF,MMP9,MYC,SHC1,SP1,TGFB1,VEGFA	 	9 (10)	9	 	hemin	 	 	 	 	 	 	 	
WSB1	enzyme	2	 	 	0.000	1.86E-04	3.50E-03	HIPK2,VHL,WSB1	 	3 (3)	2	 	 	 	 	VHL	 	 	 	 	
CSF2	cytokine	1	 	 	0.000	1.96E-04	5.20E-03	CSF2	 	4 (1)	1	ELANE,FN1,IL3,RET,SRC,TCR	caffeic acid phenethyl ester,hemin	 	CD38,collagen,CSF1,CSF2RB,EIF4EBP1,Ggt,HMGCR,IDO1,NFE2,SLC2A1,SLC2A4	FCGR1A,KLF1	 	 	 	 	
FCGR1A	transmembrane receptor	2	 	 	0.000	2.21E-04	1.59E-02	ERK1/2,FCGR1A,LYN,PI3K (family),SHC1	 	5 (5)	4	 	CSF2,IDO1,TGFB1	 	PI3K (family)	 	 	 	 	 	
nintedanib	chemical drug	2	 	 	0.000	2.33E-04	6.40E-03	FLT1,LYN,nintedanib,SRC	 	4 (4)	3	 	 	 	 	SRC	 	 	 	 	
TGFB1	growth factor	1	 	 	0.000	2.45E-04	2.16E-02	TGFB1	 	6 (1)	1	4-hydroxynonenal,caffeic acid phenethyl ester,ferric chloride,TCR	MMP8,NEDD4L,SMPD1	 	ADAM12,Alpha 1 antitrypsin,collagen,CSF1,EIF4EBP1,FLNA,mir-143,NOX4,PINK1,SLC2A1,SRC	APOC2,BAD,CD46,FCGR1A,FTH1,GATA3,HEXIM1,STAT4	 	 	 	 	
CER1	cytokine	3	 	 	0.000	2.76E-04	2.38E-02	BMP,BMP2,BMP4,CER1,ERK1/2,FLT1,NFkB (complex),Wnt	 	6 (8)	5	 	 	 	 	 	 	 	 	 	
CSF2RB	transmembrane receptor	2	 	 	0.000	3.51E-04	4.15E-02	AKT1,CSF2RB,IRS2,LYN,MAPK1,NFkB (complex),PI3K (complex),SHC1,STAT3,STAT5A	 	6 (10)	9	CD38,CSF2,IL3,IL5,SRC	 	 	 	 	 	 	 	 	
CDH16	enzyme	3	 	 	0.000	3.57E-04	4.70E-03	AKT1,CDH16,CEBPA,CEBPB,EGR1,ERK1/2,ESR1,GATA1,HRAS,MAP2K1/2,MITF,MTOR,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),RAF1,RICTOR,RPS6KA1,SGK1,SHC1,Stat3-Stat3,TNFSF11	 	10 (24)	20	 	 	 	 	 	 	 	 	 	
Stat3-Stat3	complex	3	 	 	0.000	4.12E-04	2.12E-02	CDKN1A,CEBPA,F2,HIRA,MYC,PI3K (complex),SP1,STAT3,Stat3-Stat3	 	9 (9)	9	 	 	 	 	 	 	 	 	 	
USP37	peptidase	3	 	 	0.000	4.19E-04	2.57E-02	CDKN1B,CEBPB,F2,HRAS,MYC,RARA,SP1,tretinoin,USP37	 	9 (9)	6	 	 	 	 	 	 	 	 	 	
PI 3-kinase inhibitor	chemical drug	2	 	 	0.000	4.42E-04	2.38E-02	AKT1,CEBPB,MAPK1,NOS2,PI 3-kinase inhibitor,PI3K (family)	 	5 (6)	5	 	 	 	 	PI3K (family)	 	 	 	 	
ABCB6	transporter	1	 	 	0.000	4.50E-04	2.80E-03	ABCB6	 	2 (1)	1	hemin	 	 	 	KLF1	 	 	 	 	
aldesleukin	biologic drug	3	 	 	0.000	5.03E-04	4.96E-02	aldesleukin,ERK1/2,HRAS,IL2,IL2RA,IL2RB,IL2RG,PI3K (complex),SHC1,STAT3,STAT5A,STAT6	 	6 (12)	8	 	 	 	IFNGR2	 	 	 	 	 	
Z-Asp-2,6-dichlorobenzoyl-oxymethylketone	chemical toxicant	3	 	 	0.000	5.25E-04	4.29E-02	BAX,BID,CASP3,DICER1,IL18,LPL,NFkB (complex),PI3K (complex),PRKCD,Z-Asp-2,6-dichlorobenzoyl-oxymethylketone	 	6 (10)	8	 	 	 	 	 	 	 	 	 	
MMP8	peptidase	3	 	 	0.000	5.59E-04	5.00E-03	CEBPA,CEBPB,CXCL8,EGFR,EGR1,ERK1/2,ESR1,GATA1,HRAS,hydrogen peroxide,Interferon alpha,MITF,MMP8,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),PI3K (family),SGK1,SHC1,Stat3-Stat3	 	10 (22)	20	 	 	 	 	TGFB1	 	 	 	 	
STAT4	transcription regulator	2	 	 	0.000	5.61E-04	4.69E-02	IFNG,STAT3,STAT4	 	6 (3)	3	TCR	TGFB1	 	ATF4,BAD,FURIN,MATK,PPP1R13L	 	 	 	 	 	
GATA3	transcription regulator	2	 	 	0.000	5.75E-04	4.50E-02	GATA3,IFNG,IL10,STAT4	 	6 (4)	3	TCR	IDO1,TGFB1	 	IL3,IL5	 	 	 	 	 	
CD47	transmembrane receptor	2	 	 	0.000	5.90E-04	9.30E-03	CD47,Cdc42,LYN	 	3 (3)	3	 	 	 	CSF1	 	 	 	 	 	
IFNGR2	transmembrane receptor	3	 	 	0.000	6.31E-04	3.42E-02	CEBPA,HRAS,IFNGR2,JAK1,JAK2,NOS2,PI3K (complex),SHC1,SP1,STAT1,STAT3,STAT4	 	8 (12)	8	aldesleukin	 	 	 	 	 	 	 	 	
Ifnz (includes others)	cytokine	3	 	 	0.000	6.59E-04	3.52E-02	CEBPA,HRAS,Ifnz (includes others),JAK1,JAK2,NOS2,PI3K (complex),SHC1,SP1,STAT1,STAT3,STAT4,TYK2	 	8 (13)	8	 	 	 	 	 	 	 	 	 	
CSF1	cytokine	2	 	 	0.000	6.77E-04	3.52E-02	CSF1,ERK1/2,HRAS,LYN,MAP2K1,MAPK1,MITF,NFkB (complex),PI3K (complex),SHC1,SMPD1,SRC,TNF	 	8 (13)	13	CD47,CSF2,IL3,Pdgfra-Pdgfrb,RET,TGFB1	 	 	EIF4EBP1,FN1,HMGCR,SLC2A1,SRC	SMPD1	 	 	 	 	
RET	kinase	2	 	 	0.000	6.97E-04	4.26E-02	AKT1,ATF4,ELK1,ESR1,HRAS,MTOR,PI3K (complex),RET,SHC1,SRC,STAT3	 	7 (11)	10	 	 	 	ATF4,CSF1,CSF2	 	 	 	 	 	
BAG2	other	1	 	 	0.000	7.36E-04	1.50E-03	BAG2	 	1 (1)	1	 	 	 	PINK1	 	 	 	 	 	
CDC42BPB	kinase	1	 	 	0.000	7.36E-04	1.50E-03	CDC42BPB	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
GSE1	other	1	 	 	0.000	7.36E-04	4.90E-03	GSE1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
Ggt	group	1	 	 	0.000	7.36E-04	4.90E-03	Ggt	 	1 (1)	1	CSF2,IL5	 	 	 	 	 	 	 	 	
NBR2	other	1	 	 	0.000	7.36E-04	5.40E-03	NBR2	 	1 (1)	1	phenformin	 	 	SLC2A1	 	 	 	 	 	
SLC2A12	transporter	1	 	 	0.000	7.36E-04	7.00E-04	SLC2A12	 	1 (1)	1	 	SLC2A4	 	 	 	 	 	 	 	
azide	chemical reagent	1	 	 	0.000	7.36E-04	5.40E-03	azide	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
SERPINC1	enzyme	2	 	 	0.000	7.39E-04	4.92E-02	F2,NFkB (complex),NFKBIA,NOS2,SERPINC1	 	5 (5)	4	 	 	 	 	 	 	 	 	 	
ganglioside GD1b	chemical - endogenous mammalian	3	 	 	0.000	7.53E-04	8.00E-03	CASP3,CEBPA,CEBPB,EGR1,ERK1/2,ESR1,FGF2,ganglioside GD1b,GATA1,HRAS,IL18,MITF,MYC,NFE2L2,NFkB (complex),P38 MAPK,PGR,PI3K (complex),SGK1,SHC1,Stat3-Stat3	 	10 (21)	18	 	 	 	 	IL5	 	 	 	 	
hispidulin	chemical drug	2	 	 	0.000	7.76E-04	2.78E-02	advanced glycation end-products,ERK1/2,hispidulin,MTOR,PI3K (complex)	 	4 (5)	4	 	 	 	 	 	 	 	 	 	
bumetanide	chemical drug	3	 	 	0.000	7.84E-04	8.40E-03	bumetanide,CASP3,CEBPA,CEBPB,EGFR,EGR1,ERK1/2,ESR1,GATA1,HRAS,IL18,MITF,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),PI3K (family),SGK1,SHC1,Stat3-Stat3	 	10 (21)	19	 	 	 	 	 	 	 	 	 	
PINK1	kinase	3	 	 	0.000	8.42E-04	2.57E-02	APLN,BAX,CASP3,DICER1,HIF1A,IL18,NOS2,PARP1,PINK1,VEGFA,VHL	 	8 (11)	8	BAG2,TGFB1	 	 	SLC2A1	EIF4EBP1	 	 	 	 	
SP1-c-Myc	complex	2	 	 	0.000	8.50E-04	3.45E-02	MYC,SP1,SP1-c-Myc	 	5 (3)	2	 	 	 	 	 	 	 	 	 	
pranlukast	chemical drug	3	 	 	0.000	8.53E-04	2.94E-02	AMPK,BAX,BID,CASP3,DICER1,ERK1/2,HNF4A,HRAS,IL18,Insulin,MAPK1,PGR,PI3K (complex),pranlukast,PRKCD,TP53	 	8 (16)	14	 	 	 	 	 	 	 	 	 	
methazolamide	chemical drug	3	 	 	0.000	9.00E-04	2.08E-02	CA3,CA4,CA9,methazolamide,NFkB (complex),SRC	 	4 (6)	3	 	 	 	 	CA4	 	 	 	 	
sulfacetamide	chemical drug	3	 	 	0.000	9.00E-04	2.08E-02	CA3,CA4,CA9,NFkB (complex),SRC,sulfacetamide	 	4 (6)	3	 	 	 	 	CA4	 	 	 	 	
HDL-cholesterol	complex	2	 	 	0.000	9.00E-04	1.40E-02	cholesterol,EIF4EBP1,HDL-cholesterol	 	3 (3)	2	HIF1AN,nicotinic acid	SMPD1	 	 	EIF4EBP1	 	 	 	 	
benzthiazide	chemical drug	3	 	 	0.000	9.06E-04	2.09E-02	benzthiazide,CA3,CA4,CA9,NFkB (complex),SRC	 	4 (6)	3	 	 	 	 	CA4	 	 	 	 	
chlorthalidone	chemical drug	3	 	 	0.000	9.06E-04	2.09E-02	CA3,CA4,CA9,chlorthalidone,NFkB (complex),SRC	 	4 (6)	3	 	 	 	 	CA4	 	 	 	 	
chlorothiazide	chemical drug	3	 	 	0.000	9.22E-04	2.13E-02	CA3,CA4,CA9,chlorothiazide,NFkB (complex),SRC	 	4 (6)	3	 	 	 	 	CA4	 	 	 	 	
IL5	cytokine	1	 	 	0.000	1.10E-03	1.29E-02	IL5	 	3 (1)	1	GATA3,TCR	dichloroacetic acid,ganglioside GD1b,hemin,PPIA	 	ATF4,CA4,CSF2RB,EIF4EBP1,Ggt,HMGCR,NFE2,SLC2A1,SMAD2	 	 	 	 	 	
VHL	transcription regulator	1	 	 	0.000	1.12E-03	9.60E-03	VHL	 	2 (1)	1	TRPM2	WSB1	 	FN1,FTH1	ACO1,EPAS1,HIF3A,IREB2,NOX4,PRKCI,SKP2,SLC2A1	 	 	 	 	
nicotinic acid	chemical - endogenous mammalian	2	 	 	0.000	1.16E-03	4.03E-02	ERK1/2,NFkB (complex),nicotinic acid,TDO2	 	4 (4)	3	 	 	 	HDL-cholesterol,TDO2	 	 	 	 	 	
(-)-isoproterenol	chemical drug	3	 	 	0.000	1.18E-03	1.03E-02	(-)-isoproterenol,CEBPA,CEBPB,EGFR,EGR1,ERK1/2,ESR1,GATA1,HRAS,MAPK1,MAPK3,MITF,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),PI3K (family),SGK1,SHC1,SNAI2,Stat3-Stat3	 	10 (22)	20	 	 	 	 	 	 	 	 	 	
vatalanib	chemical drug	3	 	 	0.000	1.20E-03	8.00E-03	Akt,AKT1,CASP3,CEBPA,CEBPB,EGR1,ERK1/2,ESR1,GATA1,HRAS,IL18,KDR,MITF,MYC,NFE2L2,NFkB (complex),Pdgf (complex),PGR,SGK1,SHC1,SLC2A1,Stat3-Stat3,TNFSF11,vatalanib	 	9 (24)	19	 	 	 	 	 	 	 	 	 	
C1QTNF12	other	3	 	 	0.000	1.21E-03	8.50E-03	AKT1,C1QTNF12,CEBPA,CEBPB,EGR1,ERK1/2,ESR1,GATA1,Insulin,IRS1,MITF,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),SGK1,SHC1,Stat3-Stat3,TNFSF11	 	9 (20)	18	L-dopa	 	 	 	 	 	 	 	 	
PD 173958	chemical - kinase inhibitor	2	 	 	0.000	1.24E-03	1.58E-02	LYN,PD 173958,PRKCD,SRC	 	3 (4)	3	 	 	 	 	SRC	 	 	 	 	
N-(3-(aminomethyl)benzyl)acetamidine	chemical reagent	2	 	 	0.000	1.27E-03	2.55E-02	IREB2,N-(3-(aminomethyl)benzyl)acetamidine,NOS1,NOS2	 	3 (4)	3	 	 	 	IREB2	NOS1	 	 	 	 	
GCG	other	1	 	 	0.000	1.36E-03	9.00E-03	GCG	 	2 (1)	1	 	 	 	ADP,PDX1,PPP1R3C,SLC2A1,SLC2A4,SRC	EIF4EBP1	 	 	 	 	
hemin	chemical - endogenous mammalian	1	 	 	0.000	1.40E-03	7.20E-03	hemin	 	2 (1)	1	 	 	 	ABCB6,FTH1,IDO1,SLC2A4	8-epi-prostaglandin F2alpha,ACO1,CSF2,IL5	 	 	 	 	
bazedoxifene	chemical drug	3	 	 	0.000	1.43E-03	1.91E-02	AKT1,bazedoxifene,CEBPA,ERK1/2,ESR1,estrogen receptor,GATA1,MITF,MYC,PI3K (complex),SGK1,TNFSF11	 	9 (12)	10	 	 	 	 	 	 	 	 	 	
bosutinib	chemical drug	2	 	 	0.000	1.45E-03	2.14E-02	ABL1,bosutinib,LYN,SRC	 	3 (4)	3	 	 	 	 	SRC	 	 	 	 	
8-aminoadenosine	chemical reagent	1	 	 	0.000	1.47E-03	9.10E-03	8-aminoadenosine	 	1 (1)	1	 	 	 	 	EIF4EBP1,SLC2A1,SLC2A4	 	 	 	 	
Alpha 1 antitrypsin	group	1	 	 	0.000	1.47E-03	1.50E-03	Alpha 1 antitrypsin	 	1 (1)	1	TGFB1	 	 	 	ELANE	 	 	 	 	
SNED1	other	1	 	 	0.000	1.47E-03	9.10E-03	SNED1	 	1 (1)	1	 	 	 	SLC2A1,SLC2A4	 	 	 	 	 	
TXNDC5	enzyme	1	 	 	0.000	1.47E-03	1.50E-03	TXNDC5	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
dimethyl succinate	chemical - endogenous mammalian	1	 	 	0.000	1.47E-03	1.06E-02	dimethyl succinate	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
gliclazide	chemical drug	1	 	 	0.000	1.47E-03	7.30E-03	gliclazide	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
glucose oxidase	group	1	 	 	0.000	1.47E-03	1.07E-02	glucose oxidase	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
Il18r	complex	2	 	 	0.000	1.53E-03	1.45E-02	Il18r,PI3K (complex),SRC	 	3 (3)	2	 	 	 	SRC	 	 	 	 	 	
ADAM12	peptidase	2	 	 	0.000	1.63E-03	1.81E-02	ADAM12,PI3K (complex),SRC	 	3 (3)	2	FURIN,TGFB1	 	 	SRC	 	 	 	 	 	
TTK	kinase	3	 	 	0.000	1.66E-03	4.74E-02	CDK2,CEBPA,CEBPB,L-threonine,L-tyrosine,MYC,PGR,PI3K (complex),RICTOR,SNAI2,SP1,TP53,TTK	 	9 (13)	9	 	 	 	 	 	 	 	 	 	
glycosphingolipid	chemical - other	2	 	 	0.000	1.71E-03	1.29E-02	glycosphingolipid,LYN,Secretase gamma	 	2 (3)	2	 	 	 	 	 	 	 	 	 	
GP130 dimer	complex	3	 	 	0.000	1.84E-03	4.87E-02	AKT1,CEBPB,ELK1,ESR1,GP130 dimer,HRAS,IL6ST,MITF,MTOR,MYC,NFkB (complex),PI3K (complex),RAS,SRF,STAT3,STAT5A,TSC2	 	8 (17)	14	 	 	 	 	 	 	 	 	 	
MATK	kinase	2	 	 	0.000	1.87E-03	4.41E-02	LYN,MATK,SRC	 	3 (3)	2	STAT4	 	 	 	SRC	 	 	 	 	
benzamidine	chemical - protease inhibitor	3	 	 	0.000	1.88E-03	4.46E-02	ACPP,benzamidine,ERBB2,ERK1/2,GZMK,KLK3,PI3K (complex),PLAU,SHC1	 	4 (9)	5	 	 	 	 	 	 	 	 	 	
PTGER3	G-protein coupled receptor	3	 	 	0.000	1.90E-03	2.29E-02	CEBPA,CEBPB,EGR1,ERK1/2,GATA1,HRAS,MAPK1,MAPK3,MITF,MYC,NFE2L2,PI3K (complex),PTGER3,RHOA,SGK1,SHC1,SNAI2,SP1,Stat3-Stat3	 	9 (19)	16	PDX1	 	 	 	 	 	 	 	 	
nonylphenol	chemical toxicant	3	 	 	0.000	1.98E-03	2.57E-02	Akt,ESR1,GATA1,Jnk,Mapk,MAPK1,MITF,nonylphenol,PDX1,RICTOR,SNAI2	 	8 (11)	8	 	 	 	 	 	 	 	 	 	
Pdgfra-Pdgfrb	complex	2	 	 	0.000	2.20E-03	2.52E-02	Pdgfra-Pdgfrb,PI3K (complex),SPHK1,SRC	 	3 (4)	3	 	 	 	CSF1,SRC	 	 	 	 	 	
PRKD3	kinase	3	 	 	0.000	2.20E-03	1.59E-02	Akt,CEBPA,CEBPB,EGR1,ERK,ERK1/2,ESR1,GATA1,MITF,MTORC1,MYC,NFE2L2,NFkB (complex),NOS2,PDX1,PGR,PI3K (complex),PRKD3,RICTOR,RPS6KB1,RTKN,SGK1,SHC1,SLC2A1,Stat3-Stat3	 	9 (25)	20	 	L-dopa	 	 	 	 	 	 	 	
CTNS	transporter	1	 	 	0.000	2.21E-03	2.60E-03	CTNS	 	1 (1)	1	 	 	 	TFEB	 	 	 	 	 	
FTMT	enzyme	1	 	 	0.000	2.21E-03	8.50E-03	FTMT	 	1 (1)	1	 	 	 	 	FTH1	 	 	 	 	
PPP1R3C	phosphatase	1	 	 	0.000	2.21E-03	5.40E-03	PPP1R3C	 	1 (1)	1	GCG	 	 	 	SLC2A1	 	 	 	 	
SDHA	enzyme	1	 	 	0.000	2.21E-03	9.10E-03	SDHA	 	1 (1)	1	 	PDX1,TCR	 	 	SLC2A1,SLC2A4	 	 	 	 	
SLC48A1	transporter	1	 	 	0.000	2.21E-03	1.38E-02	SLC48A1	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	chemical reagent	1	 	 	0.000	2.21E-03	1.05E-02	ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
interferon beta-1b	biologic drug	1	 	 	0.000	2.21E-03	4.70E-03	interferon beta-1b	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
RAPGEF2	other	3	 	 	0.000	2.23E-03	2.40E-02	CEBPA,CEBPB,EGR1,ELK1,ERK1/2,ESR1,GATA1,HRAS,MITF,MYC,NFE2L2,NFkB (complex),PGR,PI3K (complex),RAPGEF2,RAS,SGK1,SHC1,Stat3-Stat3	 	9 (19)	17	 	 	 	 	 	 	 	 	 	
SRC	kinase	1	 	 	0.000	2.31E-03	8.80E-03	SRC	 	2 (1)	1	ADAM12,CSF1,GCG,Il18r,IL3,NOX4,Pdgfra-Pdgfrb,TGFB1,xanthine	bosutinib,MATK,nintedanib,PD 173958	 	CD46,CSF2,CSF2RB,DAG1,PIK3CB,SLC2A1,ZAP70	NOS1	 	 	 	 	
L-tryptophan	chemical - endogenous mammalian	2	 	 	0.000	2.34E-03	3.22E-02	L-tryptophan,MTOR,PI3K (complex)	 	3 (3)	3	 	TDO2	 	 	 	 	 	 	 	
caffeic acid phenethyl ester	chemical drug	1	 	 	0.000	2.36E-03	1.43E-02	caffeic acid phenethyl ester	 	2 (1)	1	 	 	 	FTH1,TGFB1	CSF2	 	 	 	 	
nitroglycerin	chemical drug	2	 	 	0.000	2.39E-03	3.79E-02	ALDH2,MMP9,nitroglycerin,NOS1,XDH	 	3 (5)	4	 	 	 	 	NOS1	 	 	 	 	
HMGCR	enzyme	3	 	 	0.000	2.59E-03	3.98E-02	CASP3,CEBPA,ERK1/2,F2,GATA1,HMGCR,HRAS,IL18,MYC,PI3K (complex),RAS	 	7 (11)	7	CSF1,CSF2,IL5	hydroxypropyl-beta-cyclodextrin,SYVN1	 	 	 	 	 	 	 	
NKX2-5	transcription regulator	2	 	 	0.000	2.73E-03	3.34E-02	GATA1,NKX2-5,SRF	 	3 (3)	2	 	 	 	 	 	 	 	 	 	
DISC1	other	2	 	 	0.000	2.85E-03	3.52E-02	ATF4,DISC1,ERK1/2	 	3 (3)	2	 	 	 	 	ATF4	 	 	 	 	
HCAR1	G-protein coupled receptor	1	 	 	0.000	2.94E-03	1.62E-02	HCAR1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
PAK4	kinase	1	 	 	0.000	2.94E-03	8.90E-03	PAK4	 	1 (1)	1	 	 	 	 	BAD	 	 	 	 	
TDO2	enzyme	1	 	 	0.000	2.94E-03	6.20E-03	TDO2	 	1 (1)	1	nicotinic acid	 	 	 	L-tryptophan	 	 	 	 	
firtecan pegol	chemical drug	1	 	 	0.000	2.94E-03	1.18E-02	firtecan pegol	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
methylamine	chemical - endogenous mammalian	1	 	 	0.000	2.94E-03	5.40E-03	methylamine	 	1 (1)	1	 	 	 	FN1,SLC2A1	 	 	 	 	 	
phenformin	chemical drug	1	 	 	0.000	2.94E-03	1.43E-02	phenformin	 	1 (1)	1	 	 	 	NBR2,SLC2A1	ATF4	 	 	 	 	
PI3K (family)	group	1	 	 	0.000	2.96E-03	1.29E-02	PI3K (family)	 	2 (1)	1	FCGR1A,PIK3CB	PI 3-kinase inhibitor	 	FTH1,SLC2A1	ATG7,BAD	 	 	 	 	
PDX1	transcription regulator	1	 	 	0.000	3.67E-03	2.34E-02	PDX1	 	2 (1)	1	GCG	 	 	ATF4,PTGER3,SLC2A1,TFAM	SDHA	 	 	 	 	
rebastinib	chemical drug	2	 	 	0.000	3.67E-03	2.47E-02	ABL1,LYN,rebastinib	 	2 (3)	2	 	 	 	 	 	 	 	 	 	
ABCB7	transporter	1	 	 	0.000	3.67E-03	1.08E-02	ABCB7	 	1 (1)	1	 	 	 	ACO1,FTH1	 	 	 	 	 	
CDR2	other	1	 	 	0.000	3.67E-03	1.78E-02	CDR2	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
PINK1	kinase	1	 	 	0.000	3.67E-03	1.15E-02	PINK1	 	1 (1)	1	BAG2,TGFB1	 	 	SLC2A1	EIF4EBP1	 	 	 	 	
ferric chloride	chemical toxicant	1	 	 	0.000	3.67E-03	1.20E-02	ferric chloride	 	1 (1)	1	 	 	 	FTH1,TGFB1	 	 	 	 	 	
glimepiride	chemical drug	1	 	 	0.000	3.67E-03	1.78E-02	glimepiride	 	1 (1)	1	 	 	 	SLC2A1,SLC2A4	 	 	 	 	 	
histidinol	chemical - endogenous mammalian	1	 	 	0.000	3.67E-03	1.51E-02	histidinol	 	1 (1)	1	 	 	 	ATF4	 	 	 	 	 	
temsirolimus	chemical drug	1	 	 	0.000	3.67E-03	1.10E-02	temsirolimus	 	1 (1)	1	 	 	 	 	EIF4EBP1,SLC2A1	 	 	 	 	
ATF4	transcription regulator	1	 	 	0.000	4.15E-03	2.26E-02	ATF4	 	2 (1)	1	histidinol,IL5,PDX1,RET,STAT4	ATG7,DISC1,phenformin	 	APBA3,EIF4EBP1,NOX4	 	 	 	 	 	
HDAC5	transcription regulator	2	 	 	0.000	4.16E-03	4.73E-02	GATA1,HDAC5,MYOD1	 	3 (3)	2	TRPM2	 	 	 	SLC2A4	 	 	 	 	
EPAS1	transcription regulator	1	 	 	0.000	4.27E-03	3.38E-02	EPAS1	 	2 (1)	1	NOX4	HIF3A,Irp,TRPM2,VHL	 	FN1,SLC2A1	SLC2A4	 	 	 	 	
TPOR dimer	complex	2	 	 	0.000	4.40E-03	2.10E-02	IRS2,SHC1,TPOR dimer	 	2 (3)	2	 	 	 	 	 	 	 	 	 	
APBA3	transporter	1	 	 	0.000	4.41E-03	9.90E-03	APBA3	 	1 (1)	1	ATF4	 	 	SLC2A1	 	 	 	 	 	
Cbp/p300-Maf-Nfe2l2	complex	1	 	 	0.000	4.41E-03	1.09E-02	Cbp/p300-Maf-Nfe2l2	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
WDFY2	other	1	 	 	0.000	4.41E-03	1.69E-02	WDFY2	 	1 (1)	1	 	 	 	SLC2A1,SLC2A4	 	 	 	 	 	
miR-133a-3p (and other miRNAs w/seed UUGGUCC)	mature microRNA	2	 	 	0.000	4.53E-03	4.43E-02	AKT1,ERK1/2,miR-133a-3p (and other miRNAs w/seed UUGGUCC)	 	3 (3)	3	 	 	 	 	SLC2A4	 	 	 	 	
5'-guanylylimidodiphosphate	chemical reagent	2	 	 	0.000	4.59E-03	2.94E-02	5'-guanylylimidodiphosphate,ACO1,ANXA7	 	2 (3)	2	 	 	 	 	ACO1	 	 	 	 	
vinorelbine	chemical drug	3	 	 	0.000	5.03E-03	4.54E-02	AMPK,CASP3,DICER1,ESR1,HRAS,IL18,Insulin,PGR,PI3K (complex),STK11,vinorelbine	 	7 (11)	8	 	 	 	 	 	 	 	 	 	
2-mercaptoethanol	chemical - endogenous mammalian	1	 	 	0.000	5.14E-03	1.26E-02	2-mercaptoethanol	 	1 (1)	1	 	 	 	SLC2A1	IDO1	 	 	 	 	
ABL2	kinase	1	 	 	0.000	5.14E-03	1.43E-02	ABL2	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
ACO1	enzyme	1	 	 	0.000	5.14E-03	1.31E-02	ACO1	 	1 (1)	1	ABCB7	5'-guanylylimidodiphosphate,ferric ammonium citrate,hemin,VHL	 	 	FTH1	 	 	 	 	
CCNT1	transcription regulator	1	 	 	0.000	5.14E-03	1.44E-02	CCNT1	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
CTSE	peptidase	1	 	 	0.000	5.14E-03	1.02E-02	CTSE	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
LRP2	transporter	1	 	 	0.000	5.14E-03	2.14E-02	LRP2	 	1 (1)	1	CLCN5	 	 	 	 	 	 	 	 	
pictilisib	chemical drug	1	 	 	0.000	5.14E-03	1.52E-02	pictilisib	 	1 (1)	1	 	 	 	TFEB	PIK3CB,SLC2A1	 	 	 	 	
CD38	enzyme	1	 	 	0.000	5.39E-03	2.35E-02	CD38	 	2 (1)	1	CSF2	 	 	CSF2RB,EIF4EBP1,SLC2A1	 	 	 	 	 	
IL3	cytokine	1	 	 	0.000	5.81E-03	3.53E-02	IL3	 	2 (1)	1	GATA3	 	 	CSF1,CSF2,CSF2RB,EIF4EBP1,SLC2A1,SRC	ADP,BAD	 	 	 	 	
collagen	group	1	 	 	0.000	5.87E-03	1.56E-02	collagen	 	1 (1)	1	CSF2,FLNA,TGFB1	 	 	 	 	 	 	 	 	
APOC2	transporter	2	 	 	0.000	6.48E-03	3.33E-02	APOC2,LPL,MAP2K1	 	2 (3)	2	 	TGFB1	 	 	 	 	 	 	 	
FN1	enzyme	1	 	 	0.000	6.48E-03	3.64E-02	FN1	 	2 (1)	1	CSF1,EPAS1,methylamine,NOX4,VHL	 	 	CSF2,SKP2	FLNA,TCR	 	 	 	 	
FTH1	enzyme	1	 	 	0.000	6.60E-03	1.65E-02	FTH1	 	1 (1)	1	ABCB7,caffeic acid phenethyl ester,CARM1,etoposide,ferric ammonium citrate,ferric chloride,hemin,PI3K (family),PRMT1,VHL	ACO1,FTMT,IREB2,TGFB1	 	 	 	 	 	 	 	
HBP1	transcription regulator	1	 	 	0.000	6.60E-03	2.13E-02	HBP1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
IREB2	translation regulator	1	 	 	0.000	6.60E-03	2.31E-02	IREB2	 	1 (1)	1	N-(3-(aminomethyl)benzyl)acetamidine	ferric ammonium citrate,VHL	 	 	FTH1	 	 	 	 	
Irp	group	1	 	 	0.000	6.60E-03	2.43E-02	Irp	 	1 (1)	1	 	 	 	 	EPAS1	 	 	 	 	
SLC2A1	transporter	1	 	 	0.000	6.60E-03	1.39E-02	SLC2A1	 	1 (1)	1	2-mercaptoethanol,AIMP2,APBA3,astressin 2B,ATG7,azide,Calcineurin A,CCNT1,CD38,CD46,CRHR1,CSF1,CSF2,DAG1,EPAS1,GCG,gliclazide,glimepiride,glucose oxidase,glyburide,IL3,IL5,isoprenaline,KDM8,L-dopa,methylamine,MLIP,NBR2,NOS1,NOX4,PDX1,phenformin,PI3K (family),PIK3CB,PINK1,SKP2,SLC48A1,SNED1,SRC,ST6GAL1,SYVN1,TCR,TGFB1,TRPM2,WDFY2,xanthine	8-aminoadenosine,batimastat,CDR2,CRHR2,dichloroacetic acid,EIF4EBP1,ENPP2,ethyl-3-trifluoromethylbenzyl-alpha-ketoglutarate,etoposide,firtecan pegol,HEXIM1,HIF1AN,HIF3A,indican,mir-143,pictilisib,PPP1R13L,PPP1R3C,SDHA,selumetinib,SLC2A4,SORT1,temsirolimus,topotecan,VHL	 	 	 	 	 	 	 	
ST6GAL1	enzyme	1	 	 	0.000	6.60E-03	1.85E-02	ST6GAL1	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
astressin 2B	biologic drug	1	 	 	0.000	6.60E-03	1.38E-02	astressin 2B	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
cysteamine	chemical drug	1	 	 	0.000	6.60E-03	1.43E-02	cysteamine	 	1 (1)	1	 	 	 	CA4	 	 	 	 	 	
etoposide	chemical drug	1	 	 	0.000	7.09E-03	4.29E-02	etoposide	 	2 (1)	1	 	 	 	BID,FTH1	EIF4EBP1,SLC2A1	 	 	 	 	
KDM8	enzyme	1	 	 	0.000	7.33E-03	3.13E-02	KDM8	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
topotecan	chemical drug	1	 	 	0.000	7.41E-03	2.67E-02	topotecan	 	2 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
AIMP2	other	1	 	 	0.000	8.06E-03	3.20E-02	AIMP2	 	1 (1)	1	 	 	 	SLC2A1,SLC2A4	 	 	 	 	 	
CA074-methyl ester	chemical reagent	1	 	 	0.000	8.06E-03	2.30E-02	CA074-methyl ester	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
PPIA	enzyme	1	 	 	0.000	8.06E-03	3.39E-02	PPIA	 	1 (1)	1	 	 	 	 	IL5	 	 	 	 	
SORT1	G-protein coupled receptor	1	 	 	0.000	8.06E-03	2.45E-02	SORT1	 	1 (1)	1	 	 	 	SLC2A4	SLC2A1	 	 	 	 	
TAS1R3	G-protein coupled receptor	1	 	 	0.000	8.06E-03	2.04E-02	TAS1R3	 	1 (1)	1	 	 	 	EIF4EBP1	 	 	 	 	 	
ferric ammonium citrate	chemical drug	1	 	 	0.000	8.06E-03	2.16E-02	ferric ammonium citrate	 	1 (1)	1	 	 	 	FTH1	ACO1,IREB2	 	 	 	 	
teriflunomide	chemical drug	1	 	 	0.000	8.06E-03	1.95E-02	teriflunomide	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
NFE2	transcription regulator	1	 	 	0.000	8.79E-03	3.12E-02	NFE2	 	1 (1)	1	BET,CSF2,IL5,PRMT1,ZAP70	 	 	KLF1	 	 	 	 	 	
DAG1	transmembrane receptor	1	 	 	0.000	9.52E-03	3.18E-02	DAG1	 	1 (1)	1	SRC,SYVN1	 	 	NOS1,SLC2A1	 	 	 	 	 	
HIF3A	transcription regulator	1	 	 	0.000	9.52E-03	3.25E-02	HIF3A	 	1 (1)	1	 	VHL	 	 	EPAS1,SLC2A1	 	 	 	 	
SMPD1	enzyme	1	 	 	0.000	9.52E-03	1.68E-02	SMPD1	 	1 (1)	1	 	CSF1	 	 	HDL-cholesterol,TGFB1	 	 	 	 	
ADP	chemical - endogenous mammalian	1	 	 	0.000	1.03E-02	2.10E-02	ADP	 	1 (1)	1	GCG	ammonium chloride,IL3	 	 	 	 	 	 	 	
BET	group	1	 	 	0.000	1.03E-02	3.45E-02	BET	 	1 (1)	1	 	 	 	KLF1,NFE2	 	 	 	 	 	
CLCN5	ion channel	1	 	 	0.000	1.03E-02	1.76E-02	CLCN5	 	1 (1)	1	 	 	 	LRP2	 	 	 	 	 	
ENPP2	enzyme	1	 	 	0.000	1.03E-02	2.20E-02	ENPP2	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
HIRA	transcription regulator	1	 	 	0.000	1.03E-02	3.32E-02	HIRA	 	1 (1)	1	 	 	 	KLF1	 	 	 	 	 	
PNN	other	1	 	 	0.000	1.03E-02	2.59E-02	PNN	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
xanthine	chemical - endogenous mammalian	1	 	 	0.000	1.03E-02	3.58E-02	xanthine	 	1 (1)	1	 	 	 	SLC2A1,SRC	 	 	 	 	 	
CRHR1	G-protein coupled receptor	1	 	 	0.000	1.10E-02	3.32E-02	CRHR1	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
HEXIM1	transcription regulator	1	 	 	0.000	1.10E-02	2.48E-02	HEXIM1	 	1 (1)	1	 	TGFB1	 	 	SLC2A1	 	 	 	 	
SMAD6	transcription regulator	1	 	 	0.000	1.10E-02	3.11E-02	SMAD6	 	1 (1)	1	 	 	 	 	KLF1,SMAD2	 	 	 	 	
glyburide	chemical drug	1	 	 	0.000	1.10E-02	3.23E-02	glyburide	 	1 (1)	1	 	 	 	SLC2A1	 	 	 	 	 	
isoprenaline	chemical drug	1	 	 	0.000	1.10E-02	2.30E-02	isoprenaline	 	1 (1)	1	 	 	 	SLC2A1	SLC2A4	 	 	 	 	
pomalidomide	chemical drug	1	 	 	0.000	1.10E-02	3.92E-02	pomalidomide	 	1 (1)	1	 	 	 	 	KLF1	 	 	 	 	
selumetinib	chemical drug	1	 	 	0.000	1.10E-02	1.59E-02	selumetinib	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
Calcineurin A	group	1	 	 	0.000	1.17E-02	4.13E-02	Calcineurin A	 	1 (1)	1	 	 	 	SLC2A1,SLC2A4	 	 	 	 	 	
HIF1AN	enzyme	1	 	 	0.000	1.17E-02	3.60E-02	HIF1AN	 	1 (1)	1	 	 	 	HDL-cholesterol	SLC2A1	 	 	 	 	
batimastat	chemical - protease inhibitor	1	 	 	0.000	1.17E-02	3.84E-02	batimastat	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
KLF1	transcription regulator	1	 	 	0.000	1.24E-02	3.83E-02	KLF1	 	1 (1)	1	BET,BMPR1B,HIRA,NFE2,PRMT1	ABCB6,CSF2,pomalidomide,SMAD6	 	 	 	 	 	 	 	
BID	other	1	 	 	0.000	1.32E-02	4.06E-02	BID	 	1 (1)	1	etoposide	 	 	 	 	 	 	 	 	
FLNA	other	1	 	 	0.000	1.32E-02	4.19E-02	FLNA	 	1 (1)	1	TGFB1	FN1	 	collagen	 	 	 	 	 	
NTN1	other	1	 	 	0.000	1.32E-02	2.02E-02	NTN1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
SKP2	enzyme	1	 	 	0.000	1.32E-02	3.87E-02	SKP2	 	1 (1)	1	FN1	L-dopa,VHL	 	SLC2A1	 	 	 	 	 	
mir-143	microRNA	1	 	 	0.000	1.32E-02	4.18E-02	mir-143	 	1 (1)	1	TGFB1	IDO1	 	 	SLC2A1	 	 	 	 	
CRHR2	G-protein coupled receptor	1	 	 	0.000	1.39E-02	4.63E-02	CRHR2	 	1 (1)	1	 	 	 	 	SLC2A1	 	 	 	 	
NOS1	enzyme	1	 	 	0.000	1.39E-02	3.73E-02	NOS1	 	1 (1)	1	DAG1	N-(3-(aminomethyl)benzyl)acetamidine,nitroglycerin,SRC	 	SLC2A1	SMAD2	 	 	 	 	
BMPR1B	kinase	1	 	 	0.000	1.46E-02	4.49E-02	BMPR1B	 	1 (1)	1	 	 	 	KLF1	 	 	 	 	 	
EIF4EBP1	translation regulator	1	 	 	0.000	1.46E-02	4.41E-02	EIF4EBP1	 	1 (1)	1	ATF4,CD38,CSF1,CSF2,IL3,IL5,NOX4,TAS1R3,TGFB1	8-aminoadenosine,etoposide,GCG,HDL-cholesterol,MLIP,PINK1,temsirolimus	 	 	SLC2A1	 	 	 	 	
L-tryptophan	chemical - endogenous mammalian	1	 	 	0.000	1.46E-02	4.63E-02	L-tryptophan	 	1 (1)	1	 	TDO2	 	 	 	 	 	 	 	
PPP1R13L	transcription regulator	1	 	 	0.000	1.46E-02	4.82E-02	PPP1R13L	 	1 (1)	1	STAT4	 	 	 	SLC2A1	 	 	 	 	
PRKCI	kinase	1	 	 	0.000	1.46E-02	2.89E-02	PRKCI	 	1 (1)	1	 	VHL	 	 	BAD	 	 	 	 	
SLC2A4	transporter	1	 	 	0.000	1.46E-02	4.25E-02	SLC2A4	 	1 (1)	1	AIMP2,Calcineurin A,CSF2,GCG,glimepiride,hemin,SNED1,SORT1,WDFY2	8-aminoadenosine,dichloroacetic acid,EPAS1,HDAC5,isoprenaline,miR-133a-3p (and other miRNAs w/seed UUGGUCC),SDHA	 	 	SLC2A1,SLC2A12	 	 	 	 	
TFAM	transcription regulator	1	 	 	0.000	1.46E-02	4.74E-02	TFAM	 	1 (1)	1	PDX1	NOX4	 	 	 	 	 	 	 	
ammonium chloride	chemical drug	1	 	 	0.000	1.46E-02	3.93E-02	ammonium chloride	 	1 (1)	1	 	 	 	 	ADP	 	 	 	 	
dichloroacetic acid	chemical drug	1	 	 	0.000	1.53E-02	4.13E-02	dichloroacetic acid	 	1 (1)	1	 	 	 	BAD	IL5,SLC2A1,SLC2A4	 	 	 	 	
CARM1	transcription regulator	1	 	 	0.000	1.75E-02	4.38E-02	CARM1	 	1 (1)	1	 	 	 	FTH1	 	 	 	 	 	
CA4	enzyme	1	 	 	0.000	1.82E-02	2.43E-02	CA4	 	1 (1)	1	cysteamine,IL5	benzthiazide,chlorothiazide,chlorthalidone,methazolamide,sulfacetamide	 	 	 	 	 	 	 	
indican	chemical - endogenous mammalian	1	 	 	0.000	1.90E-02	4.38E-02	indican	 	1 (1)	1	 	 	 	NOX4	SLC2A1	 	 	 	 	
hydroxypropyl-beta-cyclodextrin	chemical drug	1	 	 	0.000	1.97E-02	3.46E-02	hydroxypropyl-beta-cyclodextrin	 	1 (1)	1	 	 	 	 	HMGCR	 	 	 	 	
NOX4	enzyme	1	 	 	0.000	2.04E-02	4.29E-02	NOX4	 	1 (1)	1	ATF4,indican,TGFB1	VHL	 	EIF4EBP1,EPAS1,FN1,SLC2A1,SRC	TFAM	 	 	 	 	
TRPM2	ion channel	1	 	 	0.000	2.04E-02	4.12E-02	TRPM2	 	1 (1)	1	 	 	 	ATG7,HDAC5,SLC2A1,VHL	EPAS1	 	 	 	 	
ELANE	peptidase	1	 	 	0.000	2.47E-02	4.81E-02	ELANE	 	1 (1)	1	 	Alpha 1 antitrypsin	 	CSF2	 	 	 	 	 	
TFEB	transcription regulator	1	 	 	0.000	2.76E-02	3.43E-02	TFEB	 	1 (1)	1	CTNS,pictilisib	 	 	 	 	 	 	 	 	
4-hydroxynonenal	chemical toxicant	1	 	 	0.000	2.97E-02	4.99E-02	4-hydroxynonenal	 	1 (1)	1	 	 	 	TGFB1	 	 	 	 	 	
TAF7L	transcription regulator	1	 	 	0.000	3.47E-02	4.95E-02	TAF7L	 	1 (1)	1	 	 	 	 	 	 	 	 	 	

Diseases and Bio Functions for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of L-tryptophan	2.95E-06	 	 	 	 	SLC7A5,SLC1A5	2	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of L-amino acid	1.03E-05	 	 	 	 	SLC7A5,SLC1A5	2	
Carbohydrate Metabolism, Cellular Function and Maintenance	glycolysis	Glycolysis of leukocyte cell lines	2.69E-05	 	 	 	 	SLC2A1,HK1	2	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of squamous cell carcinoma cell lines	6.64E-05	 	 	 	 	CTSB,BSG	2	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of neutral amino acid	1.34E-04	 	 	 	 	SLC7A5,SLC1A5	2	
Carbohydrate Metabolism	glycolysis	Glycolysis of cells	1.95E-04	 	 	 	 	SLC2A1,HK1,BSG	3	
Cancer, Organismal Injury and Abnormalities	growth	Growth of tumor	2.24E-04	 	 	 	 	SLC7A5,CTSB,SLC1A5,SLC2A1,LYL1,BSG	6	
Endocrine System Disorders, Organismal Injury and Abnormalities	benign thyroid nodule	Benign thyroid nodule	3.59E-04	 	 	 	 	FTL,CTSB	2	
Cellular Movement	invasion	Invasion of sarcoma cell lines	5.67E-04	 	 	 	 	CTSB,SLC2A1	2	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	differentiation	Arrest in differentiation of erythroid cells	7.24E-04	 	 	 	 	LYL1	1	
Infectious Diseases	attachment	Attachment of hepatitis B virus	7.24E-04	 	 	 	 	FTL	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	autosomal dominant L-ferritin deficiency	Autosomal dominant L-ferritin deficiency	7.24E-04	 	 	 	 	FTL	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive GLUT1 deficiency syndrome type 1	Autosomal recessive GLUT1 deficiency syndrome type 1	7.24E-04	 	 	 	 	SLC2A1	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	autosomal recessive L-ferritin deficiency	Autosomal recessive L-ferritin deficiency	7.24E-04	 	 	 	 	FTL	1	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	borderline hemoglobin A2	Borderline hemoglobin A2	7.24E-04	 	 	 	 	KLF1	1	
Cell Death and Survival	cell death	Cell death of type 1 macrophages	7.24E-04	 	 	 	 	CTSB	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Charcot-Marie-Tooth disease type 4G	Charcot-Marie-Tooth disease type 4G	7.24E-04	 	 	 	 	HK1	1	
Cardiovascular Disease, Developmental Disorder, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	dyserythropoietic congenital anemia type IV	Dyserythropoietic congenital anemia type IV	7.24E-04	 	 	 	 	KLF1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of L-lysine	7.24E-04	 	 	 	 	SLC7A5	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of lactic acid	7.24E-04	 	 	 	 	BSG	1	
Cellular Compromise, Hematological System Development and Function	enucleation	Enucleation of orthochromic normoblasts	7.24E-04	 	 	 	 	KLF1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	episodic choreoathetosis/spasticity	Episodic choreoathetosis/spasticity	7.24E-04	 	 	 	 	SLC2A1	1	
Lipid Metabolism, Small Molecule Biochemistry	extraction	Extraction of cholesterol	7.24E-04	 	 	 	 	OSBP2	1	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of ferritin inclusion body	7.24E-04	 	 	 	 	FTL	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	glut1 deficiency syndrome type 2	Glut1 deficiency syndrome type 2	7.24E-04	 	 	 	 	SLC2A1	1	
Infectious Diseases, Organismal Development	growth	Growth of Reoviridae	7.24E-04	 	 	 	 	CTSB	1	
Cellular Function and Maintenance, Cellular Growth and Proliferation, Hematological System Development and Function	hemoglobinization	Hemoglobinization of erythroid cell lines	7.24E-04	 	 	 	 	KLF1	1	
Developmental Disorder, Hematological Disease, Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	hereditary hyperferritinemia cataract syndrome	Hereditary hyperferritinemia cataract syndrome	7.24E-04	 	 	 	 	FTL	1	
Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	KLF1-related hereditary persistence of fetal hemoglobin	KLF1-related hereditary persistence of fetal hemoglobin	7.24E-04	 	 	 	 	KLF1	1	
Cell Death and Survival, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	necrosis	Necrosis of pancreatic acinus	7.24E-04	 	 	 	 	CTSB	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	neurodegeneration with brain iron accumulation 3	Neurodegeneration with brain iron accumulation 3	7.24E-04	 	 	 	 	FTL	1	
Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Respiratory Disease	neutrophilia	Neutrophilia of lung tissue	7.24E-04	 	 	 	 	BSG	1	
Cardiovascular Disease, Cell Death and Survival, Connective Tissue Disorders, Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	nonspherocytic hemolytic anemia due to hexokinase deficiency	Nonspherocytic hemolytic anemia due to hexokinase deficiency	7.24E-04	 	 	 	 	HK1	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	quantity	Quantity of actin-rich protrusion	7.24E-04	 	 	 	 	BSG	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tissue Morphology, Tumor Morphology	quantity	Quantity of non-small-cell lung cancer cells	7.24E-04	 	 	 	 	CTSB	1	
Cell Death and Survival, Hematological System Development and Function, Hematopoiesis	repopulation	Repopulation of erythroid cells	7.24E-04	 	 	 	 	LYL1	1	
Hereditary Disorder, Ophthalmic Disease, Organismal Injury and Abnormalities	retinitis pigmentosa type 79	Retinitis pigmentosa type 79	7.24E-04	 	 	 	 	HK1	1	
Cardiovascular Disease, Developmental Disorder, Hematological Disease, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	stomatin-deficient cryohydrocytosis	Stomatin-deficient cryohydrocytosis	7.24E-04	 	 	 	 	SLC2A1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	susceptibility to idiopathic generalized epilepsy type 12	Susceptibility to idiopathic generalized epilepsy type 12	7.24E-04	 	 	 	 	SLC2A1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of leucine	7.24E-04	 	 	 	 	SLC7A5	1	
Inflammatory Response	inflammatory response	Inflammatory response of cells	7.94E-04	 	 	 	 	CTSB,SLC1A5	2	
Molecular Transport	transport	Transport of molecule	9.47E-04	 	 	 	 	SLC7A5,FTL,RILP,SLC1A5,SLC2A1,HK1,BSG	7	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of cervical cancer cell lines	1.08E-03	 	 	 	 	FTL,OSBP2,BSG	3	
Cellular Movement	invasion	Invasion of squamous cell carcinoma cell lines	1.15E-03	 	 	 	 	CTSB,BSG	2	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of leukocytes	1.19E-03	 	 	 	 	CTSB,SLC2A1	2	
Infectious Diseases	entrance	Entrance of virus	1.39E-03	 	 	 	 	CTSB,BSG	2	
Post-Translational Modification	activation	Activation of glycoprotein	1.45E-03	 	 	 	 	CTSB	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	angiogenesis	Angiogenesis of pancreatic endocrine tumor	1.45E-03	 	 	 	 	CTSB	1	
Drug Metabolism	cleavage	Cleavage of coumarin	1.45E-03	 	 	 	 	CTSB	1	
Cellular Development	dedifferentiation	Dedifferentiation of hepatoma cell lines	1.45E-03	 	 	 	 	BSG	1	
Cellular Development	differentiation	Delay in initiation of differentiation of lung cell lines	1.45E-03	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function	development	Development of microvasculature	1.45E-03	 	 	 	 	CTSB	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of L-aspartic acid	1.45E-03	 	 	 	 	SLC1A5	1	
Cellular Compromise	injury	Injury of mitochondrial membrane	1.45E-03	 	 	 	 	HK1	1	
Cellular Movement	migration	Migration of glioblastoma cells	1.45E-03	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Digestive System Development and Function, Hepatic System Development and Function, Organ Development, Organismal Development, Skeletal and Muscular System Development and Function, Tissue Development	proliferation	Proliferation of hepatic stellate cells/myofibroblasts	1.45E-03	 	 	 	 	CTSB	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities, Tumor Morphology	proliferation	Proliferation of pancreatic endocrine tumor	1.45E-03	 	 	 	 	CTSB	1	
Carbohydrate Metabolism	quantity	Quantity of ribose	1.45E-03	 	 	 	 	SLC2A1	1	
Cellular Development, Cellular Growth and Proliferation	growth	Re-entry into growth of leukemia cell lines	1.45E-03	 	 	 	 	FTL	1	
Cardiovascular Disease, Organismal Injury and Abnormalities	sporadic abdominal aortic aneurysm	Sporadic abdominal aortic aneurysm	1.45E-03	 	 	 	 	FTL	1	
Immunological Disease, Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	experimental autoimmune encephalomyelitis	Symptomatic experimental autoimmune encephalomyelitis	1.45E-03	 	 	 	 	BSG	1	
Carbohydrate Metabolism, Cellular Function and Maintenance, Molecular Transport, Small Molecule Biochemistry	transmembrane transport	Transmembrane transport of D-glucose	1.45E-03	 	 	 	 	HK1	1	
Amino Acid Metabolism, Drug Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of L-dopa	1.45E-03	 	 	 	 	SLC7A5	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of mannose	1.45E-03	 	 	 	 	SLC2A1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of L-leucine	1.45E-03	 	 	 	 	SLC7A5	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of L-tyrosine	1.45E-03	 	 	 	 	SLC7A5	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	cancer	Liver cancer	1.46E-03	 	 	 	 	SLC7A5,FTL,FAM104A,TMCC2,CTSB,SLC1A5,SPECC1,SLC2A1,HK1,KEL,BSG	11	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of tumor cell lines	1.48E-03	 	 	 	 	SLC7A5,FTL,CTSB,SLC2A1,HK1,OSBP2,BSG	7	
Cellular Movement	migration	Migration of squamous cell carcinoma cell lines	1.58E-03	 	 	 	 	CTSB,BSG	2	
Cardiovascular Disease, Developmental Disorder, Hematological Disease, Organismal Injury and Abnormalities	congenital anemia	Congenital anemia	1.77E-03	 	 	 	 	HK1,KLF1	2	
Cellular Compromise, Reproductive System Development and Function	acidification	Acidification of gonadal cell lines	2.17E-03	 	 	 	 	SLC7A5	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	colony formation	Colony formation of leukemia stem cells	2.17E-03	 	 	 	 	CTSB	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	formation	Delay in formation of breast carcinoma	2.17E-03	 	 	 	 	CTSB	1	
Infectious Diseases	disassembly	Disassembly of Reoviridae	2.17E-03	 	 	 	 	CTSB	1	
Cell Cycle	G0/G1 phase transition	Entry into G0/G1 phase transition of extensively self-renewing erythroblasts	2.17E-03	 	 	 	 	KLF1	1	
Cellular Movement	invasion	Invasion of rhabdomyosarcoma cell lines	2.17E-03	 	 	 	 	SLC2A1	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	quantity	Quantity of lysobisphosphatidic acid	2.17E-03	 	 	 	 	RILP	1	
Cellular Assembly and Organization	rearrangement	Rearrangement of endocytotic vesicle	2.17E-03	 	 	 	 	CTSB	1	
Cellular Assembly and Organization, Cellular Function and Maintenance, Cellular Movement	scattering	Scattering of lysosome	2.17E-03	 	 	 	 	RILP	1	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of cellular inclusion bodies	2.33E-03	 	 	 	 	FTL,CTSB	2	
Cardiovascular System Development and Function, Cellular Movement	migration	Migration of endothelial cell lines	2.62E-03	 	 	 	 	CTSB,BSG	2	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	differentiation	Differentiation of erythroid precursor cells	2.82E-03	 	 	 	 	KLF1,LYL1	2	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	efflux	Efflux of L-glutamic acid	2.89E-03	 	 	 	 	SLC1A5	1	
Hematological Disease, Infectious Diseases	infection	Infection by Reston ebolavirus	2.89E-03	 	 	 	 	CTSB	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities, Tumor Morphology	invasion	Invasion of pancreatic endocrine tumor	2.89E-03	 	 	 	 	CTSB	1	
Cell Morphology, Hematological System Development and Function, Hematopoiesis, Tissue Morphology	morphology	Morphology of erythroid cells	2.89E-03	 	 	 	 	KLF1	1	
Cell Cycle, Cellular Assembly and Organization, Cellular Function and Maintenance, DNA Replication, Recombination, and Repair	reorganization	Reorganization of chromatin	2.89E-03	 	 	 	 	KLF1	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of galactose	2.89E-03	 	 	 	 	SLC2A1	1	
Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of butyric acid	2.89E-03	 	 	 	 	BSG	1	
Cell Death and Survival, Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	hemolysis	Hemolysis	2.97E-03	 	 	 	 	HK1,KLF1	2	
Molecular Transport	export	Export of molecule	3.11E-03	 	 	 	 	SLC7A5,SLC1A5,BSG	3	
Cell Death and Survival	cell viability	Cell viability of myeloma cell lines	3.12E-03	 	 	 	 	SLC1A5,HK1	2	
Neurological Disease	neurological disorder	Progressive neurological disorder	3.58E-03	 	 	 	 	FTL,CTSB,SLC2A1,BSG	4	
Cell Morphology, Endocrine System Development and Function, Endocrine System Disorders, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of thyroid follicle cells	3.62E-03	 	 	 	 	CTSB	1	
Cellular Assembly and Organization	aggregation	Aggregation of intermediate filaments	3.62E-03	 	 	 	 	OSBP2	1	
Cardiovascular System Development and Function, Cellular Development, Cellular Growth and Proliferation, Organismal Development	angiogenesis	Angiogenesis of tumor cell lines	3.62E-03	 	 	 	 	CTSB	1	
Tissue Morphology	degeneration	Degeneration of extracellular matrix	3.62E-03	 	 	 	 	CTSB	1	
Cellular Compromise	degradation	Degradation of autophagosomes	3.62E-03	 	 	 	 	CTSB	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of central memory T lymphocyte	3.62E-03	 	 	 	 	SLC2A1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Inflammatory Response	inflammatory response	Inflammatory response of T lymphocytes	3.62E-03	 	 	 	 	SLC1A5	1	
Cell Morphology, Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	lack	Lack of mitochondrial sheath	3.62E-03	 	 	 	 	OSBP2	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of lactose	3.62E-03	 	 	 	 	SLC2A1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of L-glutamine	3.62E-03	 	 	 	 	SLC1A5	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of L-serine	3.62E-03	 	 	 	 	SLC1A5	1	
Carbohydrate Metabolism, Molecular Transport	transport	Transport of dehydroascorbic acid	3.62E-03	 	 	 	 	SLC2A1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of L-phenylalanine	3.62E-03	 	 	 	 	SLC7A5	1	
Amino Acid Metabolism, Drug Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of levothyroxine	3.62E-03	 	 	 	 	SLC7A5	1	
Molecular Transport	transport	Transport of carboxylic acid	3.79E-03	 	 	 	 	SLC2A1,BSG	2	
Cellular Development, Cellular Growth and Proliferation, Renal and Urological System Development and Function	growth	Arrest in growth of kidney cell lines	4.34E-03	 	 	 	 	OSBP2	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	modulation	Modulation of D-glucose	4.34E-03	 	 	 	 	SLC2A1	1	
Cellular Development, Cellular Growth and Proliferation, Reproductive System Development and Function	outgrowth	Outgrowth of breast cell lines	4.34E-03	 	 	 	 	SLC2A1	1	
Tissue Morphology	remodeling	Remodeling of extracellular matrix	4.34E-03	 	 	 	 	CTSB	1	
Cellular Compromise	stress response	Stress response of bone cancer cell lines	4.34E-03	 	 	 	 	SLC1A5	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of L-triiodothyronine	4.34E-03	 	 	 	 	SLC7A5	1	
Cell Death and Survival	cell death	Cell death of carcinoma cell lines	4.54E-03	 	 	 	 	CTSB,SPECC1,HK1	3	
Cell Death and Survival	apoptosis	Apoptosis of B-lymphocyte derived cell lines	4.58E-03	 	 	 	 	SLC2A1,HK1	2	
Cellular Development, Cellular Growth and Proliferation	proliferation	Arrest in proliferation of tumor cell lines	4.77E-03	 	 	 	 	SLC7A5,OSBP2	2	
Cell Death and Survival	cell death	Cell death of blood cells	4.87E-03	 	 	 	 	CTSB,SLC2A1,HK1,LYL1	4	
Cell-To-Cell Signaling and Interaction	aggregation	Aggregation of lymphoma cell lines	5.06E-03	 	 	 	 	BSG	1	
Hair and Skin Development and Function	appearance	Appearance of hair	5.06E-03	 	 	 	 	CTSB	1	
Cellular Development, Cellular Growth and Proliferation	proliferation	Arrest in proliferation of cervical cancer cell lines	5.06E-03	 	 	 	 	OSBP2	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	cell death	Cell death of non-small-cell lung cancer cells	5.06E-03	 	 	 	 	CTSB	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation, Hematological System Development and Function	induction	Induction of Th1 cells	5.06E-03	 	 	 	 	SLC1A5	1	
Infectious Diseases	infection	Infection by measles virus	5.06E-03	 	 	 	 	BSG	1	
Cell-To-Cell Signaling and Interaction, Inflammatory Response	inflammatory response	Inflammatory response of tumor cell lines	5.06E-03	 	 	 	 	CTSB	1	
Connective Tissue Disorders, Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease, Tissue Morphology	loss	Loss of epididymal fat	5.06E-03	 	 	 	 	SLC2A1	1	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function	proliferation	Proliferation of erythroid cell lines	5.06E-03	 	 	 	 	KLF1	1	
Hematological System Development and Function, Humoral Immune Response, Lymphoid Tissue Structure and Development, Tissue Morphology	quantity	Quantity of B lymphocytes	5.06E-03	 	 	 	 	CTSB,SLC2A1,LYL1	3	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of axons	5.09E-03	 	 	 	 	CTSB,KEL	2	
Free Radical Scavenging	production	Production of reactive oxygen species	5.24E-03	 	 	 	 	FTL,SLC2A1,HK1	3	
Cancer, Organismal Injury and Abnormalities	angiogenesis	Angiogenesis of tumor	5.36E-03	 	 	 	 	CTSB,LYL1	2	
Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function, Hematopoiesis, Tissue Development	differentiation	Differentiation of hematopoietic progenitor cells	5.62E-03	 	 	 	 	KLF1,LYL1,BSG	3	
Cellular Function and Maintenance	homeostasis	Cellular homeostasis	5.68E-03	 	 	 	 	FTL,CTSB,SLC2A1,LYL1,KEL,BSG	6	
Cellular Development, Cellular Growth and Proliferation	growth	Arrest in growth of colorectal cancer cell lines	5.78E-03	 	 	 	 	SLC7A5	1	
Humoral Immune Response, Protein Synthesis	generation	Generation of antibody	5.78E-03	 	 	 	 	CTSB	1	
Carbohydrate Metabolism, Cellular Function and Maintenance	glycolysis	Glycolysis of lung cancer cell lines	5.78E-03	 	 	 	 	SLC2A1	1	
Hematological System Development and Function	hemoglobin concentration distribution width	Hemoglobin concentration distribution width	5.78E-03	 	 	 	 	KEL	1	
Cell-To-Cell Signaling and Interaction, Cellular Function and Maintenance, Inflammatory Response	phagocytosis	Phagocytosis by Sertoli cells	5.78E-03	 	 	 	 	OSBP2	1	
Infectious Diseases, Inflammatory Disease, Inflammatory Response, Neurological Disease	pneumococcal meningitis	Pneumococcal meningitis	5.78E-03	 	 	 	 	CTSB	1	
Lipid Metabolism, Small Molecule Biochemistry	transmission	Transmission of cholesterol	5.78E-03	 	 	 	 	OSBP2	1	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of erythroid precursor cells	5.92E-03	 	 	 	 	LYL1,KEL	2	
Cellular Compromise	stress response	Stress response of cells	5.92E-03	 	 	 	 	CTSB,SLC1A5	2	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of T lymphocytes	6.12E-03	 	 	 	 	SLC2A1,LYL1,BSG	3	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of immature T lymphocytes	6.50E-03	 	 	 	 	BSG	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation, Hematological System Development and Function	induction	Induction of Th17 cells	6.50E-03	 	 	 	 	SLC1A5	1	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	inflammation	Inflammation of lung tissue	6.50E-03	 	 	 	 	BSG	1	
Cancer, Cellular Movement, Connective Tissue Disorders, Organismal Injury and Abnormalities	invasion	Invasion of fibroblast-like synoviocytes	6.50E-03	 	 	 	 	BSG	1	
Carbohydrate Metabolism, Small Molecule Biochemistry, Vitamin and Mineral Metabolism	metabolism	Metabolism of ascorbic acid	6.50E-03	 	 	 	 	SLC2A1	1	
Cellular Development, Cellular Growth and Proliferation, Reproductive System Development and Function	cell proliferation	Cell proliferation of breast cell lines	6.65E-03	 	 	 	 	CTSB,SLC2A1	2	
Carbohydrate Metabolism, Cellular Function and Maintenance, Molecular Transport, Small Molecule Biochemistry	transport	Transport of D-glucose	6.73E-03	 	 	 	 	SLC2A1,HK1	2	
Infectious Diseases	infection	Infection of cells	6.83E-03	 	 	 	 	CTSB,SLC2A1,KEL,BSG	4	
Cancer, Organismal Injury and Abnormalities, Tumor Morphology	invasion	Invasion of malignant tumor	6.88E-03	 	 	 	 	CTSB,BSG	2	
Cellular Development, Hematological System Development and Function	differentiation	Differentiation of erythroid cell lines	7.22E-03	 	 	 	 	KLF1	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	growth	Growth of pancreatic endocrine tumor	7.22E-03	 	 	 	 	CTSB	1	
Cell Morphology, Skeletal and Muscular System Development and Function	morphology	Morphology of muscle cell lines	7.22E-03	 	 	 	 	CTSB	1	
Neurological Disease, Organismal Injury and Abnormalities	reactive astrogliosis	Reactive astrogliosis	7.22E-03	 	 	 	 	CTSB	1	
Cellular Compromise	stress response	Stress response of sarcoma cell lines	7.22E-03	 	 	 	 	SLC1A5	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	uptake	Uptake of glutamine	7.22E-03	 	 	 	 	SLC1A5	1	
Organismal Survival	survival	Survival of organism	7.37E-03	 	 	 	 	FTL,CTSB,SLC2A1,KLF1	4	
Cancer, Organismal Injury and Abnormalities	adenoma formation	Adenoma	7.51E-03	 	 	 	 	SLC7A5,CTSB,SLC2A1	3	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	erythropoiesis	Erythropoiesis of spleen	7.94E-03	 	 	 	 	LYL1	1	
Cellular Movement	invasion	Invasion of lymphoma cell lines	7.94E-03	 	 	 	 	CTSB	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Unverricht-Lundborg syndrome	Unverricht-Lundborg syndrome	7.94E-03	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function, Organismal Development	vasculogenesis	Vasculogenesis	8.33E-03	 	 	 	 	CTSB,KLF1,LYL1,BSG	4	
Cardiovascular Disease, Hematological Disease, Organismal Injury and Abnormalities	anemia	Anemia	8.37E-03	 	 	 	 	SLC2A1,HK1,KLF1	3	
Endocrine System Development and Function, Molecular Transport, Small Molecule Biochemistry	abnormal quantity	Abnormal quantity of thyroid hormone	8.66E-03	 	 	 	 	CTSB	1	
Cellular Assembly and Organization, Hair and Skin Development and Function	aggregation	Aggregation of melanosomes	8.66E-03	 	 	 	 	RILP	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cellular infiltration	Cellular infiltration by microglia	8.66E-03	 	 	 	 	BSG	1	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of monocyte-derived dendritic cells	8.66E-03	 	 	 	 	CTSB	1	
Skeletal and Muscular Disorders	osteolytic bone disease	Osteolytic bone disease	8.66E-03	 	 	 	 	BSG	1	
Cell Death and Survival	apoptosis	Apoptosis of cholangiocarcinoma cell lines	9.37E-03	 	 	 	 	CTSB	1	
Post-Translational Modification, Protein Degradation, Protein Synthesis	cleavage	Cleavage of glycoprotein	9.37E-03	 	 	 	 	CTSB	1	
Cell Morphology, Cellular Assembly and Organization	permeability	Permeability of mitochondria	9.37E-03	 	 	 	 	HK1	1	
Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of aromatic amino acid	9.37E-03	 	 	 	 	SLC7A5	1	
Cell Death and Survival	apoptosis	Apoptosis of hepatoma cell lines	9.52E-03	 	 	 	 	CTSB,BSG	2	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of carcinoma cell lines	9.88E-03	 	 	 	 	SLC2A1,HK1,BSG	3	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of stratum pyramidale	1.01E-02	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function, Organ Development	activation	Activation of heart	1.01E-02	 	 	 	 	SLC2A1	1	
Infectious Diseases	entrance	Entrance of HIV-1	1.01E-02	 	 	 	 	BSG	1	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of burst-forming erythroid cells	1.01E-02	 	 	 	 	LYL1	1	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	proliferation	Proliferation of tumor cells	1.02E-02	 	 	 	 	CTSB,LYL1,BSG	3	
Cellular Function and Maintenance, Small Molecule Biochemistry	homeostasis	Homeostasis of divalent cations	1.07E-02	 	 	 	 	FTL,KEL	2	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of hepatoma cell lines	1.08E-02	 	 	 	 	BSG	1	
Cell Morphology, Nervous System Development and Function, Neurological Disease, Tissue Morphology	enlargement	Enlargement of axons	1.08E-02	 	 	 	 	CTSB	1	
Infectious Diseases	infection	Infection of gonadal cell lines	1.08E-02	 	 	 	 	BSG	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	Philadelphia-positive B-cell acute lymphoblastic leukemia	Philadelphia-positive B-cell acute lymphoblastic leukemia	1.08E-02	 	 	 	 	SLC2A1	1	
Molecular Transport, Small Molecule Biochemistry	secretion	Secretion of lactic acid	1.08E-02	 	 	 	 	SLC2A1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	familial epilepsy	Familial epilepsy	1.12E-02	 	 	 	 	CTSB,SLC2A1	2	
Drug Metabolism, Nucleic Acid Metabolism, Small Molecule Biochemistry	activation	Activation of cytarabine	1.15E-02	 	 	 	 	HK1	1	
Endocrine System Disorders, Organismal Injury and Abnormalities	cold thyroid nodule	Benign cold thyroid nodule	1.15E-02	 	 	 	 	CTSB	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	catabolism	Catabolism of proteoglycan	1.15E-02	 	 	 	 	CTSB	1	
Cell Death and Survival	cell death	Cell death of acinar gland cells	1.15E-02	 	 	 	 	CTSB	1	
DNA Replication, Recombination, and Repair	cleavage	Cleavage of DNA fragment	1.15E-02	 	 	 	 	OSBP2	1	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease, Tissue Morphology, Tumor Morphology	size	Size of lung tumor	1.22E-02	 	 	 	 	CTSB	1	
Cellular Development, Cellular Growth and Proliferation, Digestive System Development and Function, Hepatic System Development and Function, Organ Development	proliferation	Proliferation of liver cells	1.23E-02	 	 	 	 	SLC7A5,CTSB	2	
Infectious Diseases	infection	Infection by RNA virus	1.23E-02	 	 	 	 	CTSB,SLC2A1,KEL,BSG	4	
Cellular Development, Cellular Growth and Proliferation, Hair and Skin Development and Function	growth	Arrest in growth of epithelial cell lines	1.30E-02	 	 	 	 	OSBP2	1	
Cancer, Organismal Injury and Abnormalities	growth	Arrest in growth of tumor	1.30E-02	 	 	 	 	SLC7A5	1	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	pigmented villonodular synovitis	Pigmented villonodular synovitis	1.30E-02	 	 	 	 	FTL	1	
Cell Death and Survival	apoptosis	Apoptosis of erythroblasts	1.37E-02	 	 	 	 	LYL1	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	damage	Damage of hippocampus	1.37E-02	 	 	 	 	CTSB	1	
Cell Death and Survival, Cell Morphology, Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	loss	Loss of Purkinje cells	1.37E-02	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function, Organismal Development	maturation	Maturation of blood vessel	1.37E-02	 	 	 	 	LYL1	1	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease, Tissue Morphology	quantity	Quantity of pulmonary metastasis	1.37E-02	 	 	 	 	CTSB	1	
Cellular Assembly and Organization	accumulation	Accumulation of lysosome	1.44E-02	 	 	 	 	CTSB	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	development	Development of erythroid cells	1.44E-02	 	 	 	 	KLF1	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of cytotoxic T cells	1.44E-02	 	 	 	 	SLC2A1	1	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	thyroid follicular adenoma	Thyroid follicular adenoma	1.44E-02	 	 	 	 	CTSB	1	
Hematological Disease, Infectious Diseases	infection	Infection by Zaire ebolavirus	1.51E-02	 	 	 	 	CTSB	1	
Skeletal and Muscular Disorders	torticollis	Torticollis	1.51E-02	 	 	 	 	FTL	1	
Hematological Disease, Immunological Disease, Infectious Diseases	infection	Infection of T lymphocytes	1.58E-02	 	 	 	 	SLC2A1	1	
Cancer, Developmental Disorder, Embryonic Development, Organismal Injury and Abnormalities	invasion	Invasion of trophoblast	1.58E-02	 	 	 	 	BSG	1	
Nervous System Development and Function	coordination	Coordination	1.62E-02	 	 	 	 	SLC2A1,KEL	2	
Cell Death and Survival	cell death	Cell death of pro-B lymphocytes	1.65E-02	 	 	 	 	CTSB	1	
Cell Death and Survival, Skeletal and Muscular System Development and Function	cell viability	Cell viability of muscle cell lines	1.65E-02	 	 	 	 	CTSB	1	
Cellular Movement	invasion	Invasion of stomach cancer cell lines	1.65E-02	 	 	 	 	BSG	1	
Cellular Function and Maintenance, Small Molecule Biochemistry	homeostasis	Homeostasis of metal ion	1.72E-02	 	 	 	 	FTL,KEL	2	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development	proliferation	Arrest in proliferation of embryonic cell lines	1.72E-02	 	 	 	 	OSBP2	1	
Carbohydrate Metabolism, Small Molecule Biochemistry	consumption	Consumption of D-glucose	1.72E-02	 	 	 	 	SLC2A1	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Differentiation of CD8+ T lymphocyte	1.72E-02	 	 	 	 	SLC2A1	1	
Organismal Injury and Abnormalities, Renal and Urological Disease	dysfunction	Dysfunction of kidney	1.72E-02	 	 	 	 	BSG	1	
Developmental Disorder, Endocrine System Disorders, Hereditary Disorder, Organismal Injury and Abnormalities, Reproductive System Disease	globozoospermia	Globozoospermia	1.72E-02	 	 	 	 	OSBP2	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	hepatocellular carcinoma	Unresectable hepatocellular carcinoma	1.72E-02	 	 	 	 	BSG	1	
Cellular Function and Maintenance, Molecular Transport, Small Molecule Biochemistry	iron homeostasis	Iron homeostasis	1.80E-02	 	 	 	 	FTL	1	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of colony-forming erythroid cells	1.80E-02	 	 	 	 	LYL1	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation, Connective Tissue Development and Function	stimulation	Stimulation of fibroblasts	1.80E-02	 	 	 	 	BSG	1	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of hepatoma cell lines	1.81E-02	 	 	 	 	SLC2A1,BSG	2	
Cell Death and Survival	apoptosis	Apoptosis	1.85E-02	 	 	 	 	CTSB,SPECC1,SLC2A1,HK1,OSBP2,LYL1,BSG	7	
Cell Death and Survival	cell death	Cell death of hematopoietic progenitor cells	1.85E-02	 	 	 	 	CTSB,LYL1	2	
Cell Morphology, Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	abnormal morphology	Abnormal morphology of acrosome	1.87E-02	 	 	 	 	OSBP2	1	
Cellular Function and Maintenance	function	Function of hematopoietic progenitor cells	1.87E-02	 	 	 	 	LYL1	1	
Post-Translational Modification, Protein Degradation	oxidation	Oxidation of protein	1.87E-02	 	 	 	 	FTL	1	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver carcinoma	Liver carcinoma	1.92E-02	 	 	 	 	SLC7A5,FTL,FAM104A,TMCC2,SLC1A5,SPECC1,HK1,KEL,BSG	9	
Reproductive System Development and Function	decidualization	Decidualization of uterus	1.94E-02	 	 	 	 	CTSB	1	
Cardiovascular System Development and Function, Organ Morphology	dilation	Dilation of left ventricle	1.94E-02	 	 	 	 	SLC2A1	1	
Gastrointestinal Disease	gastroesophageal reflux	Gastroesophageal reflux	1.94E-02	 	 	 	 	CTSB	1	
Cellular Assembly and Organization	regulation	Regulation of mitochondria	1.94E-02	 	 	 	 	KLF1	1	
Inflammatory Response	immune response	Immune response of cells	1.98E-02	 	 	 	 	CTSB,SLC1A5,OSBP2	3	
Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	hepatic injury	Hepatic injury	2.01E-02	 	 	 	 	CTSB,BSG	2	
Ophthalmic Disease, Organismal Injury and Abnormalities	high myopia	Early-onset high myopia	2.01E-02	 	 	 	 	BSG	1	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of erythroblasts	2.01E-02	 	 	 	 	LYL1	1	
Cellular Function and Maintenance	ion homeostasis	Ion homeostasis of cells	2.11E-02	 	 	 	 	FTL,KEL,BSG	3	
Connective Tissue Disorders, Hematological Disease, Hereditary Disorder, Organismal Injury and Abnormalities	beta thalassemia	Beta thalassemia	2.15E-02	 	 	 	 	KLF1	1	
Cellular Function and Maintenance, Hematological System Development and Function	function	Function of CD8+ T lymphocyte	2.15E-02	 	 	 	 	SLC2A1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Skeletal and Muscular System Development and Function	fusion	Fusion of muscle cell lines	2.15E-02	 	 	 	 	CTSB	1	
Gastrointestinal Disease, Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of salivary gland	2.15E-02	 	 	 	 	CTSB	1	
Cellular Movement	invasion	Invasion of cervical cancer cell lines	2.15E-02	 	 	 	 	BSG	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of melanoma cells	2.22E-02	 	 	 	 	CTSB	1	
Tissue Morphology	quantity	Quantity of cervical cancer cell lines	2.22E-02	 	 	 	 	BSG	1	
Infectious Diseases	infection	Viral Infection	2.22E-02	 	 	 	 	FTL,CTSB,SLC2A1,KEL,BSG	5	
Hematological System Development and Function, Tissue Morphology	quantity	Quantity of blood cells	2.25E-02	 	 	 	 	CTSB,SLC2A1,LYL1,KEL	4	
Cellular Movement	invasion	Invasion of bone cancer cell lines	2.29E-02	 	 	 	 	CTSB	1	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	non-small cell lung carcinoma	Stage I metastatic non-small cell lung carcinoma	2.29E-02	 	 	 	 	FTL	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	transport	Transport of 2-deoxyglucose	2.29E-02	 	 	 	 	SLC2A1	1	
Cardiovascular System Development and Function, Organ Development	function	Function of left ventricle	2.36E-02	 	 	 	 	SLC2A1	1	
Cancer, Organismal Injury and Abnormalities, Respiratory Disease	advanced lung cancer	Advanced lung cancer	2.42E-02	 	 	 	 	FTL,CTSB	2	
Cellular Growth and Proliferation	colony formation	Colony formation of leukemia cell lines	2.43E-02	 	 	 	 	CTSB	1	
Cancer, Organismal Injury and Abnormalities, Tissue Morphology, Tumor Morphology	size	Size of malignant tumor	2.43E-02	 	 	 	 	CTSB	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	hereditary neuropathy	Hereditary neuropathy	2.48E-02	 	 	 	 	FTL,HK1	2	
Infectious Diseases	infection	Infection of kidney cell lines	2.50E-02	 	 	 	 	CTSB,BSG	2	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver adenoma	Hepatocellular adenoma	2.51E-02	 	 	 	 	SLC2A1	1	
Cell Death and Survival	cell death	Cell death of tumor cell lines	2.56E-02	 	 	 	 	CTSB,SPECC1,SLC2A1,HK1,BSG	5	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cellular infiltration	Cellular infiltration by CD4+ T-lymphocytes	2.58E-02	 	 	 	 	BSG	1	
Carbohydrate Metabolism	metabolism	Metabolism of polysaccharide	2.59E-02	 	 	 	 	CTSB,BSG	2	
Cell Morphology, Cellular Assembly and Organization	morphology	Morphology of endosomes	2.65E-02	 	 	 	 	RILP	1	
Molecular Transport, Protein Synthesis, Protein Trafficking	localization	Localization of protein	2.65E-02	 	 	 	 	FTL,BSG	2	
Cell Death and Survival	apoptosis	Apoptosis of intestinal cell lines	2.72E-02	 	 	 	 	OSBP2	1	
Neurological Disease	movement disorder	Movement Disorders	2.77E-02	 	 	 	 	FTL,CTSB,SLC2A1,KEL	4	
Cell Death and Survival	cell death	Cell death of immune cells	2.82E-02	 	 	 	 	CTSB,SLC2A1,HK1	3	
Cell Death and Survival, Embryonic Development	apoptosis	Apoptosis of embryonic stem cells	2.86E-02	 	 	 	 	SLC2A1	1	
Behavior	circling behavior	Circling behavior	2.86E-02	 	 	 	 	FTL	1	
Tissue Morphology	degradation	Degradation of extracellular matrix	2.86E-02	 	 	 	 	CTSB	1	
Hematological Disease	hemorrhagic disease	Hemorrhagic disease	2.87E-02	 	 	 	 	CTSB,LYL1	2	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of tumor cells	2.89E-02	 	 	 	 	CTSB,BSG	2	
Cell Morphology, Organ Morphology, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders, Skeletal and Muscular System Development and Function, Tissue Morphology	abnormal morphology	Abnormal morphology of skeletal muscle cells	3.00E-02	 	 	 	 	KEL	1	
Carbohydrate Metabolism	phosphorylation	Phosphorylation of carbohydrate	3.00E-02	 	 	 	 	HK1	1	
Cell Morphology, Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	abnormal morphology	Abnormal morphology of sperm head	3.07E-02	 	 	 	 	OSBP2	1	
Developmental Disorder, Skeletal and Muscular Disorders	centronuclear myopathy	Centronuclear myopathy	3.07E-02	 	 	 	 	KEL	1	
Cellular Development, Cellular Growth and Proliferation, Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	maturation	Maturation of red blood cells	3.07E-02	 	 	 	 	KLF1	1	
Gastrointestinal Disease, Hepatic System Disease, Inflammatory Disease, Organismal Injury and Abnormalities	primary sclerosing cholangitis	Primary sclerosing cholangitis	3.07E-02	 	 	 	 	BSG	1	
Cell Morphology, Organ Development, Organ Morphology, Skeletal and Muscular System Development and Function, Tissue Morphology	size	Size of skeletal muscle cells	3.07E-02	 	 	 	 	KEL	1	
Carbohydrate Metabolism, Drug Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of hyaluronic acid	3.07E-02	 	 	 	 	BSG	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cellular infiltration	Cellular infiltration by phagocytes	3.08E-02	 	 	 	 	CTSB,BSG	2	
Cancer, Organismal Injury and Abnormalities	nonhematologic malignant neoplasm	Nonhematologic malignant neoplasm	3.13E-02	 	 	 	 	SLC7A5,FTL,RILP,TMCC2,SLC2A1,OSBP2,BSG,ELOF1,FAM104A,CTSB,SLC1A5,SPECC1,KLF1,HK1,LYL1,KEL	16	
Cellular Assembly and Organization, Tissue Development	formation	Formation of fibrils	3.14E-02	 	 	 	 	CTSB	1	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of lung cancer cell lines	3.15E-02	 	 	 	 	SLC2A1,HK1	2	
Cardiovascular System Development and Function, Tissue Morphology	quantity	Quantity of endothelial cells	3.21E-02	 	 	 	 	CTSB	1	
Carbohydrate Metabolism	metabolism	Metabolism of carbohydrate	3.31E-02	 	 	 	 	CTSB,SLC2A1,BSG	3	
Cell Death and Survival	apoptosis	Apoptosis of carcinoma cell lines	3.35E-02	 	 	 	 	CTSB,SPECC1	2	
Cell Death and Survival	apoptosis	Apoptosis of kidney cancer cell lines	3.35E-02	 	 	 	 	SLC2A1	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Humoral Immune Response, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Arrest in differentiation of B lymphocytes	3.42E-02	 	 	 	 	LYL1	1	
Endocrine System Disorders, Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	insulitis	Insulitis	3.42E-02	 	 	 	 	CTSB	1	
Cell-To-Cell Signaling and Interaction, Cellular Growth and Proliferation	stimulation	Stimulation of cells	3.49E-02	 	 	 	 	SLC1A5,BSG	2	
Cell Death and Survival, Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities, Tissue Morphology	neurodegeneration	Neurodegeneration of Purkinje cells	3.49E-02	 	 	 	 	CTSB	1	
Hematological System Development and Function	mean corpuscular hemoglobin concentration	Mean corpuscular hemoglobin concentration	3.56E-02	 	 	 	 	KEL	1	
Cell Death and Survival	apoptosis	Apoptosis of lung cell lines	3.63E-02	 	 	 	 	SPECC1	1	
Carbohydrate Metabolism, Energy Production, Small Molecule Biochemistry	oxidation	Oxidation of D-glucose	3.63E-02	 	 	 	 	SLC2A1	1	
Cardiovascular System Development and Function, Cell Morphology, Cellular Development, Organismal Development, Tissue Development	tubulation	Tubulation of endothelial cell lines	3.63E-02	 	 	 	 	BSG	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	cervical carcinoma	Cervical carcinoma	3.71E-02	 	 	 	 	CTSB,BSG	2	
Cellular Movement	invasion	Invasion of breast cancer cell lines	3.71E-02	 	 	 	 	CTSB,BSG	2	
Cellular Movement	cellular infiltration	Cellular infiltration by myeloid cells	3.84E-02	 	 	 	 	CTSB,BSG	2	
Neurological Disease	neurodegeneration	Neurodegeneration	3.90E-02	 	 	 	 	FTL,CTSB	2	
Cellular Movement	migration	Migration of ovarian cancer cell lines	3.91E-02	 	 	 	 	BSG	1	
Dermatological Diseases and Conditions, Neurological Disease, Organismal Injury and Abnormalities	allodynia	Allodynia	3.98E-02	 	 	 	 	CTSB	1	
Cellular Movement	invasion	Invasion of epithelial cell lines	3.98E-02	 	 	 	 	BSG	1	
Hematological System Development and Function, Hypersensitivity Response, Inflammatory Response, Tissue Morphology	quantity	Quantity of mast cells	3.98E-02	 	 	 	 	CTSB	1	
Cancer, Organismal Injury and Abnormalities	tumor burden	Tumor burden	3.98E-02	 	 	 	 	CTSB	1	
Neurological Disease, Organismal Injury and Abnormalities	progressive encephalopathy	Progressive encephalopathy	4.03E-02	 	 	 	 	FTL,CTSB	2	
Organismal Injury and Abnormalities, Reproductive System Disease	infertility	Infertility	4.08E-02	 	 	 	 	OSBP2,BSG	2	
Cellular Development, Cellular Growth and Proliferation	proliferation	Proliferation of prostate cancer cell lines	4.15E-02	 	 	 	 	SLC7A5,HK1	2	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	concentration	Concentration of D-glucose	4.16E-02	 	 	 	 	SLC2A1,HK1	2	
Tissue Morphology	quantity	Quantity of cells	4.18E-02	 	 	 	 	CTSB,SLC2A1,LYL1,KEL,BSG	5	
Organismal Survival	organismal death	Organismal death	4.19E-02	 	 	 	 	SLC7A5,FTL,CTSB,SLC2A1,KLF1,BSG	6	
Cellular Development, Embryonic Development, Organismal Development, Tissue Development	differentiation	Differentiation of trophoblast	4.19E-02	 	 	 	 	BSG	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Development	hematopoiesis	Hematopoiesis in embryo	4.19E-02	 	 	 	 	KLF1	1	
Cell Death and Survival	apoptosis	Apoptosis of fibrosarcoma cell lines	4.26E-02	 	 	 	 	CTSB	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	autosomal recessive nonsyndromic mental retardation	Autosomal recessive nonsyndromic mental retardation	4.26E-02	 	 	 	 	SLC2A1	1	
Cellular Function and Maintenance, Connective Tissue Development and Function, Skeletal and Muscular System Development and Function, Tissue Development	function	Function of osteoclasts	4.33E-02	 	 	 	 	SLC1A5	1	
Hematological System Development and Function	mean corpuscular volume	Mean corpuscular volume	4.33E-02	 	 	 	 	KEL	1	
Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry	phosphorylation	Phosphorylation of L-threonine	4.33E-02	 	 	 	 	HK1	1	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of reticulocytes	4.40E-02	 	 	 	 	KEL	1	
Cell Death and Survival	apoptosis	Apoptosis of tumor cell lines	4.49E-02	 	 	 	 	CTSB,SPECC1,SLC2A1,BSG	4	
Tissue Development	disassembly	Disassembly of extracellular matrix	4.61E-02	 	 	 	 	BSG	1	
Cellular Movement	cell movement	Cell movement of bone cancer cell lines	4.67E-02	 	 	 	 	CTSB	1	
Hematological System Development and Function, Hematopoiesis	development	Development of hematopoietic system	4.73E-02	 	 	 	 	KLF1,LYL1	2	
Cancer, Cellular Development, Cellular Growth and Proliferation, Organismal Injury and Abnormalities, Tumor Morphology	proliferation	Proliferation of cancer cells	4.74E-02	 	 	 	 	CTSB,BSG	2	
Cellular Function and Maintenance, Hematological System Development and Function	function	Function of CD4+ T-lymphocytes	4.74E-02	 	 	 	 	SLC2A1	1	
Organismal Injury and Abnormalities, Reproductive System Disease	azoospermia or oligozoospermia	Azoospermia or oligozoospermia	4.78E-02	 	 	 	 	OSBP2,BSG	2	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	benign rolandic epilepsy	Benign rolandic epilepsy	4.81E-02	 	 	 	 	SLC2A1	1	
Cellular Compromise, Lipid Metabolism, Small Molecule Biochemistry	peroxidation	Peroxidation of lipid	4.88E-02	 	 	 	 	FTL	1	
Cellular Compromise, Inflammatory Response	degranulation	Degranulation of neutrophils	4.92E-02	 	 	 	 	FTL,CTSB	2	
Cellular Movement	invasion	Invasion of tumor cell lines	4.98E-02	 	 	 	 	CTSB,SLC2A1,BSG	3	

Tox Functions for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Liver Fibrosis, Liver Proliferation	proliferation	Proliferation of hepatic stellate cells/myofibroblasts	1.45E-03	 	 	 	 	CTSB	1	
Liver Hyperplasia/Hyperproliferation	cancer	Liver cancer	1.46E-03	 	 	 	 	SLC7A5,FTL,FAM104A,TMCC2,CTSB,SLC1A5,SPECC1,SLC2A1,HK1,KEL,BSG	11	
Renal Proliferation	growth	Arrest in growth of kidney cell lines	4.34E-03	 	 	 	 	OSBP2	1	
Liver Proliferation	proliferation	Proliferation of liver cells	1.23E-02	 	 	 	 	SLC7A5,CTSB	2	
Renal Dysfunction	dysfunction	Dysfunction of kidney	1.72E-02	 	 	 	 	BSG	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Unresectable hepatocellular carcinoma	1.72E-02	 	 	 	 	BSG	1	
Liver Hyperplasia/Hyperproliferation	liver carcinoma	Liver carcinoma	1.92E-02	 	 	 	 	SLC7A5,FTL,FAM104A,TMCC2,SLC1A5,SPECC1,HK1,KEL,BSG	9	
Cardiac Dilation	dilation	Dilation of left ventricle	1.94E-02	 	 	 	 	SLC2A1	1	
Liver Damage	hepatic injury	Hepatic injury	2.01E-02	 	 	 	 	CTSB,BSG	2	
Liver Hyperplasia/Hyperproliferation	liver adenoma	Hepatocellular adenoma	2.51E-02	 	 	 	 	SLC2A1	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Hepatocellular carcinoma	5.90E-02	 	 	 	 	FTL,FAM104A,BSG	3	
Renal Necrosis/Cell Death	cell viability	Cell viability of kidney cell lines	6.32E-02	 	 	 	 	SLC2A1	1	
Liver Cirrhosis	primary biliary cirrhosis	Primary biliary cirrhosis	7.07E-02	 	 	 	 	BSG	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	development	Development of hepatocellular carcinoma	7.61E-02	 	 	 	 	BSG	1	
Liver Necrosis/Cell Death	apoptosis	Apoptosis of hepatocytes	1.12E-01	 	 	 	 	CTSB	1	
Liver Fibrosis	fibrosis	Fibrosis of liver	1.17E-01	 	 	 	 	CTSB	1	
Liver Proliferation	proliferation	Proliferation of hepatocytes	1.25E-01	 	 	 	 	SLC7A5	1	
Cardiac Enlargement	hypertrophy	Hypertrophy of heart cells	1.28E-01	 	 	 	 	CTSB	1	
Cardiac Dysfunction	dysfunction	Dysfunction of heart	1.70E-01	 	 	 	 	SLC2A1	1	
Cardiac Necrosis/Cell Death	cell death	Cell death of cardiomyocytes	1.80E-01	 	 	 	 	HK1	1	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cell lines	2.58E-01	 	 	 	 	HK1	1	

Regulator Effects for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM

Networks for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	AMIGO2,ANGPT4,ANGPTL1,AURKA,Akt,Arnt-Hif1a,BSG,CTSB,Cyp2j9,ELOF1,ERAP2,ERK,FTL,FYB2,HIF3A,HK1,INSRR,IkB-NfkB,Insulin,KEL,KLF1,MLIP,MPC1,MTORC1,NFkB (complex),SCD5,SLC1A5,SLC2A1,SLC3A1,SLC48A1,SLC7A5,TCR,TP73-AS1,Tsc1-Tsc2,Vegf	26	10	Amino Acid Metabolism, Molecular Transport, Small Molecule Biochemistry	
2	top_hub_genes_F03_F4 - 2019-05-09 10:09 PM	ATAD2,AVEN,BCL2L1,CD53,CRYAA/CRYAA2,CYB5B,DDX25,DIP2A,DPH1,FAM104A,FOXRED1,GALNT10,GIMAP1-GIMAP5,HSPB3,HSPD1,Ige,LALBA,LYL1,MORC4,MPDU1,NXF1,Nrg1,OSBP2,RAB12,RAB34,RAB7B,RILP,RNF144B,SLC25A39,SPECC1,SRM,TMCC2,VPS36,YARS2,antigen	14	6	DNA Replication, Recombination, and Repair, Energy Production, Nucleic Acid Metabolism	

My Lists for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
My Lists	 -log(p-value)	Ratio	Molecules 

Tox Lists for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
Ingenuity Toxicity Lists	 -log(p-value)	Ratio	Molecules 
Increases Liver Damage	2.68E00	2.11E-02	CTSB,BSG
Protection from Hypoxia-induced Renal Ischemic Injury (Rat)	2.54E00	2.5E-01	SLC2A1
Liver Proliferation	1.87E00	8.1E-03	SLC7A5,CTSB
Increases Cardiac Dysfunction	1.38E00	1.69E-02	SLC2A1
Renal Necrosis/Cell Death	1.21E00	3.55E-03	SLC2A1,HK1
TR/RXR Activation	1.15E00	1E-02	SLC2A1
NRF2-mediated Oxidative Stress Response	7.69E-01	3.91E-03	FTL
Cardiac Necrosis/Cell Death	7.09E-01	3.36E-03	HK1
Liver Necrosis/Cell Death	6.84E-01	3.14E-03	CTSB
Xenobiotic Metabolism Signaling	6.29E-01	2.72E-03	FTL
Cardiac Hypertrophy	6.29E-01	2.72E-03	CTSB

My Pathways for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
My Pathways	 -log(p-value)	Ratio	Molecules 

Analysis Ready Molecules for My Projects->AIH_WGCNA->top_hub_genes_F03_F4 - 2019-05-09 10:09 PM
ID	Symbol
BSG	BSG
CTSB	CTSB
ELOF1	ELOF1
FAM104A	FAM104A
FTL	FTL
HK1	HK1
KEL	KEL
KLF1	KLF1
LYL1	LYL1
OSBP2	OSBP2
RILP	RILP
SLC1A5	SLC1A5
SLC2A1	SLC2A1
SLC7A5	SLC7A5
SPECC1	SPECC1
TMCC2	TMCC2

